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ABSTRACT

MARTIN G. BIALER. Acid Lipase Deficiency and Lipid Storage in Wolman's
Disease and E60D-Treated Cells in Culture. (Under the direction
of RUSSELL A. VINCENT, JR., Ph.D).
Fibroblasts obtained from a child with Wolman's disease and
maintained in culture demonstrated acid lipase deficiency, reached
senescence prematurely and exhibited an abnormal #5 chromosome.

When

cyt,ogenetic analysis was repeated on frozen and stored cells, the
chromosomal defect could no
were present.

l~nger

be

demonstrated~

but other anomalies

The karyotypes of other Wolman's disease cell cultures and

the parents of the proband were normal.

The mother's fibroblasts

had reduced acid lipase activity, consistent with a carrier-state, but
the father's fibroblasts had normal acid lipase activity.
possible to

classi~y

It was

a culture as Wolman's disease, carrier or normal by

the ability of medium from the culture to reduce the lipid stored in a
Wolman's disease cell culture.

The culture of the proband stored

more lipid than other Wolman's disease cultures.

1wo enzymes present in fetal calf serum possessing paraoxonase
activity could be differenti.ated by their sensitivity to heating at

56°C.

The esterase inhibitor E60D was

s~ightly

more toxic to Wolman's

disease than to normal cells, and was also toxic to E. coli.
Normal cells exhibited lipid storage when treated with lO-4M
E600, but a more pronounced time-dependent accumulation of lipid

occurred at

lo-1M

E600.

p-Nitrophenol, the major metabolite of

E600. had little effect on lipid storage.

The amount of lipid stored

varried directly with the serum concentration and was unaffected

vii

by heat inactivation of the serum.

Histochemical stains and biochemical

analyses were performed on cultured fibroblasts.

Both Wolman's disease

and E600-treated cells showed star.age of tr.i&lycerides and cholesteryl

esters, although one Wolman's disease culture had a normal level of
triglyceride.

The E600-treated cells also showed a large increase

in phospholipid and small increases in free cholesterol and free fatty
acid.

Wolman's disease cells treated with E600 showed increases

comparable to the normal E600-treated cells, but no increase of free
!;~fatty

acid was seen.

Wolman's disease he terozygotes appeared to have

normal amounts of lipid.

Lipid in Wolman's disease and E600-treated

cells fluoresced in ultraviolet

~ight.

Cholesteryl esters of

untreated norma.1 cells had more stearic (18 :0) than -oleic (18 :l(9)
acid, whereas cholesteryl esters in Wolman's

disease~

E600-treated

cells, and fetal calf serum had three times more oleic than stearic
acid, suggesti.ng that serum lipid was taken up, but not degraded, in
Wolman's disease and E600-treated cells.
Three Wolman's disease cell cultures exhibited geneti'C
deficiency of acid lipase.

Normal fibroblasts had acid lipase activity,

but possessed little neutral lipase activity.

Acid lipase activity

of normal cells was inhibited by E600.
Wolman's disease cells resembled normal cells by scanning
electron microscopy_

Except in a perinuclear zone which also had

not stained with oil red 0 or neutral red, the cytoplasm of E600treated cells had numerous bumps which appeared to form ridges along
the path of actin stress filaments.

viii

Normal cells treated with free fatty acid or cholesterol,
and Wolman's disease cells treated with free fatty acid, exhibited

lipid storage in

l~rge)

generally stored in

peripheral lipid droplets.

sma~let:

Lipid was

granules closer to the nucleus in

E600-treated and Wolman's disease cells.

E600-treated cells showed

increased numbers of lysosomes by neutral red staining and had increased

numbers of dense bodies ultrastructurally.

The dense bodies of Wolman's

disease and E600-treated cells sometimes contained lipid clefts which
probably consisted of cholesteryl ester.

The dense bodies accumulated

colloidal
lysosomes.
. . gold, suggesting their identity with secondary
.
"

Alth~ugh

some differences were observed, E600-treated cells resembled

Wolman's disease cells histochemically, biochemically, and
ultrastructurally.
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· .INTRODUCTION
The lysosomal enzyme, acid lipase, was first characterized by Stoffel
and Greten (1) in 1967.

The enzyme was first reported in human tissue by

Patrick and Lake (2) in 1969.

In this report, its deficiency in liver and

spleen of patients with Wolman's disease was causally linked wi.th this dis-

order.
In Wolman's disease, triglycerides and cholesteryl esters accumulate
in many tissues of the body.

The liver is particularly affected, storing

so much lipid that it assumes a yellow color.
tract are also severely affected.

The spleen and gastrointestinal

Both adrenals exhibit extensive punctate

calcification, a feature that is virtually pathognomonic of the disease.
The disease appears to follow an autosomal recessive pattern of inheritance.
Infants with Wolman's disease. usually present with vomiting or diarrhea

and steatorrhea within the first few weeks of life.
hepatosplenomegaly is already
progresses. The infants

ShOll

present,·becom~g

At this time,

massive as the disease

severe malabsorption and fail to thrive.

Patients have not benefited from the few attempts at dietary management,
and generally die before six months of .age.

Comprehensive reviews of

Wolman's disease have been wri1;:ten by Patrick and Lake (3) and by Sloan
and Frederickson (4).

It is a severe disorder of lipid storage, an

indication of the importance of the acid lipase enzyme to normal function.
Its severity may also be related to the high concentration of triglycerides
and cholesteryl esters in the body and the continual
substances.

~rnover

of these

Thus interference with one step in the metabolic pathway

may lead to rapid and excessive storage of lipid.

2
Cholesteryl ester

sto~age

disease is another rare disorder, of lipid

metabolism that appears to be caused by a deficiency of acid lipase (5,6).
BC7tiever t the disease is generally less severe than Wolman's disease.

Many

patients have shown no symptoms other than hepatosplenomegaly and
hypercholesterolemia, altho,ugh in some families the disease may have a
more malignant course leading to death in childhood (7).
from patients with cholesteryl ester

sto~age

Altho.ugb cells

disease have more residual

acid lipase activity than those from patients with Wolman's disease (5,8),
the differences have not been deemed to be sufficient to account for

the dramatic difference in the courses of the two disorders.

However,

Goldstein II ale (9) have shown that intact cells from patients with
cholesteryl ester storage disease, which have stored· approximately three

times as mucbcholesteryl ester as cells derived from normal individuals,

show nearly one-third the acid lipase activity of normal cells.

The same

cells exhibit only 5% of normal activity when assays are carried out on
cell-free extracts.

Similar studies with intact Wolman's disease cells

have not been done.

Thus, a small difference in acid lipase activity

when only a small amount of activity is present may make a big difference
in the amount of ljpid stored and the course of the disease.

Brown et ale

(10) have shown that only 10% of normal acid lipase activity may be

necessary for normal function.
The acid lipase enzyme has a pH optimum of approximately 4 to 5 in
most assay systems (9,11-15). It is active toward both triglycerides
and cholesteryl esters (15), hydrolyzing both lipids at their ester
linkages.

The enzyme is probably identical to acid cho1esteryl esterase

·'(15) and acid esterase (13).

It 1s relatively resis taRt to E600

3

(diethyl p-nitrophenyl phosphate, paraoxon), which allows it to be
classified as an A-type esterase (16,17) because lipases are considered to

be a subtype of esterases (18).

It is resistant to diisopropylfluorophos-

phate, activated by Triton X-lOO and taurodeoxycholate and inhibited by
cyanide, p-hydroxymercuribenzoate, sodium chloride, 4,4'-diethylaminoethoxyhexestrol, chloroquine and other substances (11,12,14,19,20).
Acid lipase is a true lipase because it is more active toward esters of
1~ng

chain fatty acids than esters of short chain fatty acids (13,17).

The enzyme is fairly labile and this has made it difficult to purify
',(12,13).
ac~ivity

Cortner.!! al. (8) have separated three bands of acid lipase
by cellogel electrophoresis, only one of which was absent in

Wolman's disease and cho1esteryl ester storage disease.

Four discrete

bands of acid esterase activity have been separated by isoe1ectric
focusing on
I

polyacrylamid~

gel (13,21).

Wolman's disease fibroblasts

were unable to hydrolyze the substrate used to assay acid esterase
activity (13,21).

It is possible that the isozymes may have different

substrate specificities (8).
Acid lipase can be shown to be important to normal function, but

neither Wolman's disease nor cho1esteryl ester storage disease is very
important epidemiologically.

Tnere have been approximately 30 cases of

Wolman t s disease reported since it was first described :in 1956 (3,8).
Cholesteryl ester storage disease has been observed in about 14 patients
since its first description in 1966 (7).· However, the study of Wolman's
disease has pointed out the clinical importance of acid lipase activity
and the study of acid lipase deficient cells has contributed to an
understand~ng

of the way lipid is metabolized and stored in the body.

4

Ather9sclerosis is a disease' characterized by plaques of lipid
material accumulating in the arterial wall.

Much of this lipid is

cholesteryl ester, and in two animal model systems the cholesteryl ester

bas been shown to accumulate in lysosomes of aortic smooth muscle cells
(22-24).

Several reports have suggested that a relative deficiency of

acid lipase may be involved in the pathogenesis of atherosclerosis (22-26).
E600 has been used extensively to inhibit esterases in biochemical
(27,28) and histological (16,29) studies.

Aldridge (27) used the

sensitivity of esterases to E600 to distinguish between A and B-type
B-type esterases are inhibited by lO-SM E600 whereas A-type

esterases.

e~terases are not inhibited by IO-3M E600.

B-type esterases include

acetylcholinesterase (27) and liver microsomal esterase (28).

A-type

esterases include acid lipase (16) and serum paraoxonase (30-32), a
serum enzyme that is able to cleave E600.
esterases by
site (33).

transferr~ng

a

E600 appears to inhibit

diethylphosphoryl radical to the active

Although E600 has been in use as an esterase inhibitor

since 1950 (34), it has rarely been used to treat whole cells.
studies on whole cells have been

toxico~ogical

The few

(35,36) or concerned

with acetylcholinesterase activity of chick embryo muscle cultures

(37,38).

No studies of the effect of treating cultured cells with an

esterase inhibitor for several days have been published.
In this dissertation, the results of decreased acid lipase

activity

i~

genetically deficient Wolman's disease cells and in normal

cells rendered dysfunctional for acid lipase by E600 treatment are

presented.

111e dissertation consists of a general introduction, four

research sections t and an overall discussion bringing together all the

5

f1nd~ngs

from which certain conclusions are drawn •. The first .research

section presents an unusual case of Wolman's disease and studies on
both the parents and the proband.

The second research section

presents evidence that E600 treatment induces lipid s tor,age in normal
cells and .provides a histochemical comparison of the lipid stored in
Wolman's disease cells with that stored in E600-treated normal and

Wolman's disease cells.

The third research section presents biochemical

studies of Wolman's disease and E600-treated cells, including lipid
analyses and enzymatic studies.

In the fourth research section, the

ultrastructure of Wolman's disease and E600-treated cells is compared

and electron microscopic cytochemical studies are presented.
Some results from the first section have been published as an
abstract in Laboratory

Inves~igations

(39).

Some results from the

second section have been published as an abstract in the Journal of Cell
Biol,ogy (40).

Data

from the second and third sections have been

submitted to Experimental Cell Research.

Early results from the fourth

)

section were presented at the Southeastern Electron Microscopy Society
Meeting (41).

RESEARCH SECTION I

Introducti'!!

Wolman's disease appears to be an inherited disorder with an
autosomal recessive mode of transmission.
as males.

Of 15 families studied, first cousin marriages were involved

in three families, and

four (3).
8ibl~ngs

Females are affected as often

sibl~gs

of the proband were affected in at least

Furthermore, parents of affected children and some of the
of affected children have levels of acid lipase activity about

half that of. normal individuals, falling into the range expected for
. heterozygotes or carriers of a given trait (3,8,17 ,42).

Carriers for

Wolman's disease can thus be detected by assay of acid lipase activity.
Fibroblasts cultured from Wolman's disease patients exhibit acid

lipase deficiency (8,19,42,43) and accumulate tz:ig1ycerides and choles teryl
esters (42).
Kyrialddes

The lipid can be visualized by staining with oil red 0 (8,42).

!:! a1.

(42) reported increased lipid storage in fibroblasts

cultured from the father of a Wolman's disease patient, but this result has
not been repeated.
Cultured fibroblasts have been shown to release lysosomal

en~es

into the medium and to take up the enzymesagatn by a specific receptormediated endocytosis (44,45).

Cells lacking a specific lysosomal enzyme

are able to take up that enzyme if it is introduced into the medium.

If .

medium from normal cells, in which acid lipase can be detected (10), is
added to Wolman's disease cells, the acid lipase is endocytosed and

transported to lysosomes, where it is able to degrade stored
tr,iglycerides and

~holesteryl

esters.

Thus medium fran normal cells

can be used to correct the Wolman's disease defect

~n

vitro

(10,42).

7

Cy~ogenetic

analysis has only been reported on one Wolman's disease

patient (46), and this patient had a normal chromosome complement.
Cytogenetic abnormalities are rarely seen in patients with lipid storage
disorders.

This section presents a case of Wolman's disease in which a

chromosomal anomaly was observed, and includes studies done on the parents

of this child to provide information about the inheritance of the defect.

-

Materials and Methods

2

Cells were routinely cultured as monolayers in 25 cm

Cell Culture:

polystyrene tissue culture flasks (Falcon or
in S'ml of

~agle's

Mdnimal Essential Medium

or Dulbecco's modified MEM (GIBCO).

Corn~ng).

~)

They were grown

with Earle's salts (Flow)

The medium was supplemented

with 8%

or .15% fetal calf serum (FCS) (GIBCO) and 1% antibiotic-antimycotic lOOX

mixture (GIBeO).

The same media supplemented with 3% FCS were used for

cell maintenance.

acetate filters

Medium was filtered sterilized through 0.22 }lm cellulose

(~1illipore).

Medium was changed weekly.

Cells were

incubated in a tissue culture incubator (WEDeO) at 37.SoC
atmosphere of 5 to 8% CO •
2

in a humidified

Manipulations requiring sterile' condi tions

were carried out in vertical laminar flow hoods (Baker Co.)

For

subcultivation, cells were rinsed with 2.5 ml of pH 7.0, Puck's balanced
salt solution (PBS) (NaC!, 145.4 roM; Na HP0 , 845.3
2
4

~M;

NaH P0 , 362.3 VM)

2

4

and exposed to 1.5 ml of pH 7.1 trypsin solution (DIFCO) (0.25% trypsin

with NaCl, 136.9 roM; Kel, 5.4 roMj dextrose, 5.6 mM; NaHC0 , 7.1 mM; EDTA,
3

537.3

~M)

until cells detached.

Medium was then added, and the cells were

transferred to new culture flasks.
Cell Origin:
(G~1606J

Fibroblast cultures derived from Wolman's disease patients

GM-2211), normal donors (GM-179, GM-316, GM-37, GM-498, IMR-90), '

a Wolman's disease heterozygote (GM-212l), and a Olediak-Higashi syndrome

8

patient

(GM-~075)

were obtained as monolayers from the Institute for

Medical Research (Camden, N.J.).
GM-3557,

G~3558,

Other cultures (GM-2109, GM-2520, SaJo,

JoAI) were established from skin biopsy specimens.

GM-2109 (P), a Wolman's disease culture, was established by J.F. Rogers

from abdominal skin obtained 2 hr postmortem.
established from forearm biopsies:

The other cultures were

GM-2520from a 10 year old girl with

Bloom's syndrome, JoAl from a 13 year old boy with metachromatic
leukodystrophy, SaJo from a 20.year old normal woman, GM-3557 (M) from the

24 year old mother and GM-3558 (F) from the 28 year old father of the child

-from whom culture GM-2109 (P) was established.
were established with the help of J.F. Rogers.
local anesthetic was applied.

The latter three cultures
The skin was cleansed and a

A piece of skin was excised with a sterile

scalpel and placed in sterile medium with antibiotic.

The biopsy specimen

was then cut into fragments approximately 0.5 mm in size and each was
positioned with 4 or 5 other
culture flasks.

f~agments

2
in one of several 25 cm tissue

Two and one-balf ml of medium was added to the top

surface of each inverted flask and the biopsy fragm.,ents were allowed to
attach to the bottom for 1 hr at room' temperature.

Each flask was then

carefully turned right side up and the medium was allowed to cover slowly,
but not loosen, the fx:agments.

mentioned above.
were subcultured.

subculture 1.

The flasks were incubated at 37.5 °c as

When o~tgrowths covered about 75% of the flask, the cells

,The resultant f ibroblas t cultures were designa ted

Further subcultures were noted and the pass,age level of the

cells was recorded for all experiments.
Cytogenetic analysis:

Chromosomes were examined from fibroblast cell

cultures of Wolman's disease (GM-2109 cP), GM-22l1, GM-1606) and the
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parents of the local proband (GM-3557 (1), GM-3558 (F».

Chromosomes from

lymphocytes cultured from the parents were also examined.

Fibroblast

cultures were treated with colchicine (Lilly) for 3 to 5 hours, swelled in

hypotonic solution (.075 M KCl) for 35 minutes and fixed in 3:1 methanolacetic acid.

Lymphocytes were treated with colchicine for 1.5 hours,

hypotonic for .25 minutes, and fixed similarly.
slides and burst by air or blaze drying.

The cells were spread on

The slides were stained with 4%

Giemsa (Fisher) in pH 6.B phosphate blttfer.

For chromosome banding, slides

were treated with 2 ml of pancreatin (GIBCO) in 7 m1 of Hank's balanced salt
"solution (GIBCO) and 7 ml of distilled water for 5-6 sec at 37°C.
Chromosomes were counted and examined from at least 20 cells per

culture.

Karyotypes were prepared on several of the best typical cells and

an any atypical cell.

The initial karyotypes of GM-2l09 (P) were prepared

under the direction of J.F. Rogers.
Acid lipase assay:

Cells were assayed for acid lipase activity by the

fluorometric method of Cortner et ale (B).

Generally cells were grown to

2
confluency in a 75 cm flask and trypsinized about one week later.

The

cells were washed three times in PBS, pelleted and frozen at -70°C until the
time of assay.

Substrate, 4-methylumbelliferyl oleate (Research Products

.. International) dispersed in lecithin (Sigma) and taurodeoxycholate (Sigma),

was prepared beforehand and frozen.

On

the day of assay the substrate was

thawed and one volume was diluted with 7 volumes of 0.2 M acetate buffer,
pH 4.0.

Eight ml was placed into 25 ml Ehrlenmeyer flasks.

Four-

methylumbellifercne standards were prepared at concentrations of 0.1 to
2.0 nmol/ml.

Then PBS was added to the cell pellets and they were sonicated

on ice with a microtip sonicator (Heat Systems - Ultrasonics).

Centrifuging

at this point could increase the measure of activity. but might also
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decrease the reproducibility of the assay. One hundred

~l

of enzyme source

was added to a prewarmed Ehr1enmeyer flask of substrate, mixed, and
incubated in a 37°C water bath.

At 2, 4, 8 and 16 min, 2 ml of reaction

mixture was removed and read on an Aminco-Bowman spectrofluorophotometer

at an excitation
448 nm.

wavel~ngth

of 322 nm and an emission wavelength of

Protein concentration in each sample was measured the next

day by the method of Lowry I I a1.

(47) or Bradford (48).

The specific

activity of acid lipase was expressed as nmol of substrate hydrolyzed
per min per ,mg protein.
Correction by conditioned medium:

To test the ability of medimn from

different cell lines to correct the Wolman's disease defect, GM-1606
Wolman's disease cells were seeded onto 22 x 22 mm coverslips in 35 x 10 mm
culture dishes at a concentration of 5 x 10

4-

cells per dish.

Treatment

with conditioned medium was begun 3 days later and lasted 2 weeks.
conditioned medium, with 3% FCS, was pipetted from various
1 m1 was added to 2 m1 of fresh medium, with 8% FCS.

The

cultures~

and

Medium was changed

'every 3 days and conditioned medium was made up fresh each time.

After

2 weeks, the cells were fixed for 2 hr in calcium buffered formalin

(4% formaldehyde from paraformaldehyde and 2% calcium acetate, pH
7.0-7.2).

The coverslips were stained with oil red 0 and hematoxylin (49)

and mounted on slides
coverslip

wer~

wit~ glycero~

gel.

One hundred cells on each

graded from 0 to 3 in intervals of 0.5 for the extent of

sudanophilic granulation.

Briefly, grade 0 represents no lipid" grade 3

represents 100% of the cytoplasm exhibiting lipid staining and grade 1.5
represents 50% of the cytoplasm staining.
different grades are shown in Figure I.

Cells exemplifying the
After grading, the numbers were
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summed to give a representation of the amount of lipid present on a

liven coverslip.
Enzyme addition:

Coverslip cultures of GM-1606 were prepared as in the

correction by conditioned medium experiment.

The cells were treated with

concentrations of porcine pancreatic lipase (Sigma L-2253), hog

vary~ng

liver carboxyesterase (Sigma E-9627) or bovine pancreatic cholesterol
esterase

(~igma

C-3766) and Sendai virus (10

3

parti~les per culture

dish) to increase permeability of the membrane.

After 3 days, the

cells were fixed, stained, and graded as in the correction by conditioned
" medium experiment.
Results
Case Report:
Following a normal delivery. the proband had diarrhea
~irst

three weeks at home.

dur~ng

his

At 3 months, the child was admitted to the

Medical University Hospital with massive hepatosplenomegaly and abdominal
distension.

No pre-beta or alpha lipoprotein activity was seen by

electrophoresis.

A liver biopsy showed marked fatty change with massive

periportal fibrosis.

A flat plate of ·the abdomen revealed bilateral

punctate calcification of the adrenals, virtually

Wolman's disease.

The patient died at .age 4 months.

malnourished black male infant.
spleen, adrenals and lymph nodes.

color

Bud

pat~ognomonic

of

Autopsy revealed a

There was enlargement of the liver)
The liver appeared yellow-orange in

microscopic examination revealed fat vacuoles in hepatocytes

and cholesteryl ester clefts in periportal

revealed increased
cholesterol.

t~iglycerides,

macrop~ges.

Lipid analysis

choles teryl es ter, and free

The presentation was typical of Wolman's disease, the

first case reported in a black child.
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cytogenetic Analysis:
Karyotypes of the GM-2l09 (P) Wolman's disease cell culture
established from the proband revealed a

l~ng

B-group chromosome (Fig. 2)

which, from banding, appeared to be the US chromosome (Fig. 3).
l~g

The

chromosome was present in 19 of 21 cells examined, and the 2 cells

in which it was not seen were very contracted and difficult to analyze.
lCaryotypes from the GM-1606

(~ig.

4) and GM-22l1 (Fig. 5) Wolman's

disease cell lines revealed normal female and male karyotypes
respectively_
(~ig.·

Karyotypes from GM-3557 (M) (Fig. 6) and GM-3558 (F)

7), cell cultures established from the parents of the proband,

~evealed

no balanced translocation or other abnormality, and the banded

kaxyotypes

(~igs.

8,9) did not reveal the presence of a condition

(e._g. an inversion) that

~ight

dispose the proband to a translocation

event.
Cells that had been frozen and stored at the Institute for
.Medical Research were utilized to repeat cytogenetic analysis on the
G~2~09

(P) culture.

cells were obtained.

The cells grew poorly and only 10 metaphase
Of these, 7 were normal, 2 showed a different

abnormality of the #5 chromosome (5p+) and 1 cell showed a partial
duplication of the #1 chromosome.

No cells showed the anomaly

seen initially.

Acid lipase assay:

The cells of the proband showed a deficiency of acid

lipase that was comparable to the 2 other Wolman's disease cell cultures
assayed (Table 1).

If this case followed classical Mendelian inheritance, both
parents would be expected to be carriers for the disease and the
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TABLE 1
ACIn LIPASE ACTIVITY OF CELL HOMOGENATES PREPARED FROM CULTURED

CELLS OF CLINICALLY NORMAL AND WOLMAN'S DISEASE DONORS.a

ACT IVI TYb

SAMPLE

,Apparently normal:
GM-179

1.51

GM-316

0.93

SaJo

1.98

IMR-90

0.71

GM~2520

2.23
Mean

1.47

+ 0.65

Wolman's disease:

GM-1606

0.27

GM-221l

0.46

GM-2109 (proband)

0.29
Mean

0.34 + 0.10

8Confluent cell cultures were trypsinized, pe11eted, and
sonicated on ice on a microtip sonicator. Homogenates were
assayed for acid lipase by a fluorometric technique.
bNanomoles of 4-methylumbelliferyl oleate hydrolyzed per
min per mg protein.

chromosomal anomaly would be unrelated to the disease process.
when acid lipase was assayed, only the mother (GM-3557 (M»
carrier for Wolman's disease (Table 2).

normal level of acid lipase activity.

However,

appeared to be a

The father (Glf-3558 (F»

had a

Although this assay is somewhat

variable, the mother could be classified as a-carrier in 2 of 3 assays
tho,ugh appeari,ng normal in one assay and the father could be classified

as normal in 3 of 3.
Correction by conditioned medium:

Media from. normal ce11 cultures and

a Chediak-Higashi cell culture caused a reduction of lipid storage in
Wolman's disease cells (Fig. 10), thus demonstrating the ability to
correct the Wolman's disease defect.
showed little correction.

Media from Wolman's disease cells

Medium from a known carrier for Wolman's

disease showed some ability to correct the defect but not as much as
seen in media from normal cells.
proband were also examined.

Media from the parents of the local

Media from the father's cells corrected the

defect as well as normal cells whereas media from the mother's cells
did not.

All the results correlated well with the level of acid lipase

activity of the different cultures, providing further support for
classifY~ng

disease.

the mother, but not the father, as a carrier for Wolman's

When the extent of lipid in the treated cultures was plotted

,against the acid lipase activity shown in assay 1 of Table 2, the points

fit a straight line (Fig. 11), statistically s,ignificant by linear
regression (p<.05).
Cells from the parents exhibited little oil red 0 staining whereas
cells from the proband had large numbers of oil red 0 positive, granules
(Fig. 12).
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'tABLE 2

ACID LIPASE ACTIVITY OF CELL HOMOGENATES PREPARED FROM CULWRED CEu..S
OF CLINICALLY NORMAL. WOLMAN'S DISEASE AND WOLMAN'S DISEASE
HETEROZYGOTE DONORS, AND OF THE PARENTS OF THE PROBAND.

SAMPLE

Assay 1

Assay 2

GM-179

2.49

2.58

1.00

GK-37

2.28

2.59

1.10

GM-498

1.04

2.77

1.06

GM-2075

1.87

5.17

2.50

GM~2520

1.29

1.68

<1.96

Assay 3

Apparently normal:

GM-1492

1.52

GM-1493

5.43

JoAl

1.85

1.88
1.24

GM-316
Mean

1.79

± 0.62

2.95

± 1.52

1.53 + 0.58

Wolman's disease:
GM-1606

0.16

GM-2211

0.41

Mean

0.29

0.17

0.12
0.29

± 0.18

0.21

±. 0.12

Carrier:
GM-2121

1.00

1.08

Proband's parents:
CM-3551 (M)

0.96

2.87

0.57

GM-3558 (F)

2.28

3.13

2.22

~anomoles of 4-methylumbelliferyl oleate hydrolyzed per min per mg
prote~n.

~igure

showi,ng

th~

1.

Cytoplasmic lipid accumulation in cultured 'cells

grades (0-3.0) into which cells were classified according

to the extent of oil red 0 positive staining they exhibited.
with oil red 0 and hematoxylin.

X550.

Stained
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o

2.0

0.5

1.0

1.5

3.0

-f~gure

2.

Karyotype of the GM-2109 (P) cell culture derived

from a child with Wolman's disease.
extra material on the

l~ng

The male karyotype exhibited

arm of a B-group chronnsome (arrow).

Stained-with Giemsa.

~igure

3.

B-group chromosomes of Wolmants disease cell-culture

GM-2109
(P) stained by a Giemsa banding procedure.
.
-

the

l~ng

G~2109

arm appeared to be the #5 chromosome.
(P) culture was 46,XY,5q+.

The chromosome with

The karyotype of -the
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4.

Karyotype of Wolman's disease cell culture. GM-1606.

Metaphase spreads from this culture exhibited a normal female karyotype
(46,XX).

Stained with Giemsa.

~igure

5.

Karyotype of Wolman's disease cell culture GM-2211.

Metaphase spreads from this culture exhibited a normal male karyotype
(46,XY).

Stained with Giemsa.
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6.

Karyotype of the GM-3557 cell culture, derived from

the mother of the proband (GM-2l09).

Metaphase spreads from this

culture exhibited a normal female karyotype

(46,~{).

Stained with

Giemsa.

~igure

7.

Karyotype .of the GM-3558.cell culture, derived from

the father of the proband (GM-2109).
culture exhibited a

norm~l

Metaphase spreads from this

male karyotype (46,XY).

Stained with

Gie~sa.
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8. - Giemsa-banded karyotype of .the GM-3557 cell culture,

derived from .the mother of the proband (GM-2109).

The karyotype

appears normal.

~igure

9.

Giemsa-banded karyotype of the GM-3558 .cell -culture,

derived from -the father of the proba.nd (GM-2109).
appears normal.

The karyotype
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F,1gure 10.
G~1606

Correction by conditioned medium • . Cells from the

Wolman's disease culture, -which normally.stores lipid) were

grown for 2 weeks in the presence of conditioned media from other cell
cultures.

(A) Fresh medium; (B) GM-1606, Wolmanfs disease; (e) GM-2121,

Wolman 18 disease heterozygote; CD) GM-179, normal; (E)
of. proband; (F) GM-3558, father of proband.

and hematoxylin.

~igure

sto~age

G~1-3557,

mother

Stained with oil red .0 .

X350.

11.

Correlation of the extent of correction of lipid

in GM-1606, Wolman's disease cells treated with conditioned

media from other cell cultures with the acid lipase activity of those
cell cultures (Assay 1 of Table 2).

One hundred cells per point were

graded for the extent of oil red 0 positive granulation according to
the grades shown in ~ig. 1 and the numbers were sumned to give the

ordinate value.
~egression

The line was statistically significant by linear

(p<.05).
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2.0
Acid Lipase Activity (nmoiAntnAng protein)
1.0

3.0

Figure

•

Cytoplasmic lipid accumulation in

a patient with WolDIan' s disease and his parents.

s cultured
(A)

GM-3558,

the proband; (B) GM-2l09, Wolman's disease proband;
(C) GM-3557, mother of the proband.

Significant

was only seen in cells from the proband.
hematoxylin.

X700.

accumula

Stained with oil red 0
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,

·
Enzyme addition:

0.002

~g/ml),

23~

Wolman's disease cells treated with lipase (0.2, 0.02,

esterase (0.2, 0.02,0.002 .mg/ml), and cholesterol esterase

(0.4, 0.04, 0.004 .mg/ml) showed no difference in lipid stor.age from
untreated cells.
Discussion
The initial cytogenetic
actively proliferati.ng,

find~ngs,

s~ggested

obtained when the cells were

that the karyotype of the proband

contained a translocation onto the long arm of chromosome 115 (46,XY,5q+).

Cyt.ogenetic and

b1ochem~cal

studies of the parents were undertaken in

order to elucidate the possible relation between a chromosomal anomaly
and the inheritance of a lipid

sto~age

disease.

Results of acid lipase

assays and conditioned media addition experiments indicated that, though

the mother appeared to be a carrier for Wolman's disease, the father

appeared to have a normal level of acid lipase.

This focused attention

on the father, because without deletion of his normal acid lipase gene
the child would not have been' expected to exhibit the symptoms of
Wolman's disease.

The father's karyotype did not show a balanced

translocation nor was there evidence of an inversion or other
rearrangement that could have disposed the proband to a translocation
event.

The results could be explained by a translocation during meiosis

of the germ cells of the father or during an
~gote.

Cells from

~he

early mitotic division of the

proband had been submitted to the Institute for

Medical Research for ultracold storage.

During the course of the studies,

we encountered difficulties in recovering a proliferative culture from
storage, presumably due to the early senescence of the culture.

After

approximately 10 attempts, a proliferating culture was obtained and the

cytogenetic

~alyseswererepeated.
alth~ugh

5q+ anomaly and,

On this occasion" no cells showed the

two cells showed. other rearrangements involving

chromosome lIS, seven cells appeared normal.

The cells still stored lipid.

These results raise the possibility that the initial cytogenetic finding
did not truly reflect the karyotype of the proband.
Alth~ugh

the karyotypes of cultured human fibroblasts are usually

stable and diploid (50,51), it is possible for clones with marker

chromosomes to emerge in culture (52,53).

Even though the aberrent

chromosome was present in at least 90% of the metapbasesexamined, it
remains possible that in a poorly

proliferat~ng

culture the population

could become enriched by selection for clonally derived cells with increased
proliferative capaci ty and an associated cYt':0genetic anomaly.

If the

proband had a normal karyotype, the father should have been a carrier for
Wolman's disease.

His apparently normal level of acid lipase activity may

have been a false negative due to individual
a.ctivity and variation in the, assay.

in acid lipase

If this is true, further cases of

Wolman's disease may appear in this family.
son

variation~

If the proband were not the
.

.

of the presumed father, the true father could stil1 be a carrier or his

karyotype could contain a balanced translocation.

The possibility that this

case of Wolman's dise'ase followed an X-linked recessive mode of inheritance
cannot be ruled out.

However, few diseases normally inheri ted autosomally

can be inherited as X-lined recessives (54,55).

The fact that only one

. gene product appeared to be affected favors the hypothesis that the
karyotype of the proband was normal because most chromosome aberrations

result in multiple developmental

an~malies.

In favor of the linkage of the acid lipase defect to the
cyt,ogenetic anomaly were the normal level of acid lipase in the fa ther and
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the presence, of the cyt,agenetic anomaly in the cells of the proband before
ultracold storage and the manifestation of senescence.

The GM-2109 (P)

culture reached senescence after only 18 population doublings (Research
Section II), and senescent cultures characteristically exhibit increased
aneuploidy and tetraploidy (56).
and

freez~ng

at this time.

The effects of senescence, lipid storage,

on the emergence of karyotypically distinct cells are unclear
It is possible that an initial translocation which deleted

the acid lipase gene was susceptible to further genetic rearrangement
and was lost.

In this, case,

the cells might appear to have a

alth~ugh

normal chromosome complement, a small deletion might still be present.
deletion from the q terminal end of chromosome
the initial cytogenetic findings.
this region, it might exhibit

A

U5 wou1d be consistent with

If the acid lipase gene were located in

l~age

with diphtheria toxin sensitivity, a

marker which has been localized to the

5ql5~5qter

region (57).

If Wolman's

disease was caused by the translocation in this case, future children in
this family would not be expected to inherit Wolman's disease.
. No final conclusions about the inheritance of this case of Wolman's
disease can be drawn.

If the couple should have another child with

Wolman's disease, it would appear likely that the chromosomal anomaly was
an artifact of tissue culture. . If the acid lipase gene is mapped to
chromosome

US it would appear likely that the proband had a chromosomal

aberration and the other conclusions discussed above would follow.
Mapping experiments on acid lipase are currently being conducted by other
laboratories (P. Coates, personal communication).
The enzymes (lipase, esterase, cholesterol esterase) added to the
Wolman's disease culture should have been able to degrade some of the
stored lipid •. The fact that they did not s,uggests that the enzymes

26

. did not reach the lysosomes where the lipid was stored, or that their pH
optima

differe~

enzyme activity_
the cell.

greatly from the lysosomal pH, resulting in minimal
It is also possible that the enzymes were unable to enter

The activities of the enzymes were not Checked prior to their

use, so the possibility that a loss of activity had occurred cannot be
ruled out.
It is difficult to evaluate the effect lipid storage may have had
on cell

.ag~ng

or karyotypic instability in the GM-2l09 (P) culture, but it

is possible that lysosomal neutral lipid

sto~age

may have more profound

effects on cultured cells than is currently believed.

RESEARCH SECTION II

Introduction
The esterase inhibitor, E600 (diethyl p-nitrophenyl phosphate), is
an extremely toxic substance.

the trade name paraoxon.

It has been employed as a pesticide under

Parathion, the sulfur analogue of E600, is still

in wide use as a pesticide.

In the insect's body, the parathion is

oxi.dized to E60D, which blocks

acetylcholinesterase activity and

ultimately' kills the insect (36).

Although E60D is much more toxic to

whole animals than either parathion or the hydrolysis product of E60D,
p-nitrophenol, the toxic relationships may be reversed in cultured cells.
Both parathion and p-nitrophenol are more toxic to BeLa cells and fibroblasts than E600 (36), tho.ugh this result was not seen in chick embryo
muscle cells (38).

As mentioned previously, E600 has been used to differentiate
between B-type (E600-sensitive) esterases and A-type (E600-resistant)
esterases (27).

Although E600 appears to inactivate most esterases by

phosphorylat:i:ng the enzymes at their active site, an A-type esterase
present in mammalian sera which binds normally can remain active,
presumably by releasing the phosphoryl group, thus catalyzing the
hydrolysis of E600 to p-nitrophenol (30).

This esterase or "paraoxonase"

activity of mammalian sera has been much studied (30-32,58) and can be
reduced by the use of inhibitors such as EDTA and aluminon (31) or heat
inactivation (32).

This section presents evidence that treating fibroblast cultures
with E600 induces lipid storage in the cells.

Different parameters of

E60o-induced lipid storage, including dose and time dependence, origin _
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of the lipid., and histochemical characterization of the lipid are shown.
Other histochemical data will be presented to compare lipid storage in
different Wolman's disease cell lines, to compare the effect of adding
various lipids to normal and Wolman's disease cell cultures, and to
determine the effect of E600 treatment on neutral red granules.

The

effect of E600 on bacterial cultures is also shown.
Materials and

~£thods

E600 Treatment:

Stock solutions of E600 (S.igma Chemical Co.) were prepared

in 100% ethanol at 200X the desired final concentration.
received 0.5% of the stock solution.

Treated cells

Controls were treated with 0.5%

ethanol, a concentration which is reportedly not harmful to cultured cells
(35) and appeared to have no effect on lipid storage.

In

curve experiment, the E600 was carried in 1% ethanol.

Cell cultures were

usually exposed to E600 1 to 4 days after
to fresh medium shortly before each
Paraoxonase Inactivation:
cle~n

seed~ng.

c~nge

th~

growth

Stock E600 was added

of medium.

Fetal calf serum (FCS, GIBCO) was pipetted into

sterile plastic test tubes and heated at 56°C or 70°C in a water bath

or subjected to gamma radiation in a ·gammator (Isomedix, Inc.) for specified
periods.

HEM without phenol red (GIBCO) but

contain~ng

, -3
10 M E600 was prepared

with 3% FCS, 8% FeS, and 15% FCS for each inactivation time.
lacki.ng serum or E600 were prepared.

Controls

Tubes with 5 m1 of the different

media were incubated at 37°C for 4 days and the p-nitrophenol formed by
the hydrolysis of E600 was assayed according to the method of Aldridge

(30).

p-Nitrophenol was extracted with 5 ml of n-butanol-toluene (1:1).

From the upper layer, 2.5 ml was drawn off and 1.5 ml of 20% ammonium
qydroxide 1n 100% ethanol was added to it.
5 m1 with approximately 1 m1 of

n-butanol~

The volume was adjusted to
toluene.

The absorbance of

the samples was read on a Gilford spectrophotometer at a wavelength of
420 nm.

p-Nitrophenol standards were prepared in medium and treated

similarly.

The concentration of p-nitrophenol in each sample was calculated

from the linear
Growth Curve:

~egression

of the standard curve.

Normal fibroblasts (GM-179 or SaJo) and Wolman's disease

fibroblasts (GM-2l09 (P) or GM-l606) were seeded into 35 x 10 mm culture
dishes at a concentration of 5 x 10

4

cells per dish.

No less than 24

hr later, treatment with different concentrations ·of £600 was begun.

At this time 3 culture dishes for each culture were trypsinized and
counted in a hemocytometer.

At days 2, 4, 8, 12 and 16, 3 culture dishes

each for untreated normal, treated normal, untreated Wolman's disease, and
treated Wolman's disease cultures were trypsinized and counted in a
hemocytometer.

A trypan blue viability stain (59) was performed on every

culture counted.

The counts for the 3 cultm'e dishes were averaged,

. givi:ng one value + standard deviation that represented the ntmlber of
cells in a given culture
Relative Toxicity:

on'~

given day.

Normal fibroblasts (GM-179) and Wolman's disease

fibroblasts (GM-1606) were seeded into 35 x 10 mm culture dishes at a
concentration of 5 x 10

4

cells per dish.

After 24 hr the cells were

treated with vary~ng concentrations of E600 (4 x lO-1K~ 2 x IO-3M, IO-3M,
-4
-4
5 x 10 M, 10 M, none) in HEM supplemented with 15% PeS.

At 2 days and

6 days, 3 culture dishes per E600 concentration were trypsinized and

counted, and the counts were averaged.

The percentage of nonviable

cells was determined by trypan blue staining and used to calculate the
number of viable cells.

The percent inhibition was calculated for the

different E600 concentrations and the 1DSO determined (35).

30

Dose and Time Dependence:

Normal fibroblasts (GM-37, GM-316) and Wolman ~s

disease fibroblasts (GM-l606) were seeded onto 22 x 22 mm sterile coverslips

in 35 x 10 mm culture dishes at a density of 5 x 10 4 cells per dish.

The

cells were treated with varying concentrations of E600 (IO-2M, 3 x lO-3M,

lO-3M, 3 x IO-4M, lO-4 M, IO-SM, IO-6M, none) in HEM plus 8% FCS heat
inactivated 1 hr at 56°C.

The cells were fixed after specified periods

(0.5, 1, 2, 4, 8, 12 and 16 days) in an aqueous solution of 4% formaldehyde

and 2% calcium acetate for 1 to 2 hr.

The coverslips were stained with oil

red 0, counterstained with hematoxylin, and scored for the extent of oil
red 0 positive
. Histochemistry:

stain~ng

as described in Research Section I (Fig. 1) •

Normal fibroblasts (SaJo, GM-179, GM-37) and Wolman's

disease fibroblasts (GM-2l09 (P),.GM-l606, GM-2211) were seeded and fixed
as in the dose and time dependence experiments .d·escribed above.

in the Gomori esterase procedure was for 10 min.

Untreated cells and

cells treated with IO-3M E600 for 4 to 9 days were examined.

. techniques employed are shown. in Table 3.

Fixation

'The staining

Most s.tain reactions were

carried out in accordance with standard protocols for lipids (49) and
complex carbohydrates (60).
. the method of Landing et a1.

The

perm~nganate-aldehyde

(61) and Gomori's «-naphthyl acetate method

for esterases was performed according to the

(18).

fuchsin folloWed

procedur~

given by Hunt

Unstained, unfixed cells were examined for autofluorescence on a

Zeiss Photomicroscope II with an HBO 200 mercury source, a BG3 excitation
filter, and 41 and 53 barrier filters.

Formaldehyde-fixed cells were

examined by phase contrast microscopy.
Comparison of Wolman's Disease Cell Cultures:
(G~l-2109

Wolman's disease fibroblasts

(P), GM-1606, GM-2211) were grown on coversl1ps and fixed as des-

cribed in the dose and time dependence experiments above.

One coverslip of
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GM-221l was trypsinized and allowed
The coverslips were stained

wit~

tore~attacnfor

7 hr be!ore fixation.

oil red 0, counterstained with hematoxylin,

and scored for the extent of oil red 0 positive staining as described
in Research Section I (Fig. 1).
Lipid Addi tion :

Normal (G1:1-498) and Wolman's disease (GM-1606) cells

were seeded on covers lips in culture dishes as described in the dose
and time dependence experiment.

The cells were treated with varying

concentrations of cholesterol (Sigma), cholesteryl ester (cholesteryl
palmitate, Sigma), and free fatty acid (cis-vaccenic acid, Sigma).

After

dissolving 4 .mg of lipid in 0.5 ml of ethanol, which required heating
for cholesteryl palmitate, the solutions were added to 8 ml of FeS with
mixi~g

and serial dilutions were made.

Dulbeccots MEM supplemented with

8% FCS was prepared with the different lipid-fortified fetal calf sera.
The cells were treated for 3 days and then fixed, stained, and scored for
the extent of oil red 0 staining as described in Research Section
(~ig.

I-·

_1).

Effect of Serum Concentration and Inactivation:

Normal cells (GM-3l6)

were seeded on coverslips in culture dishes as described in the dose .
and time dependence experiments above.

Replicate cultures were grown

in media with lO-3M E600 and either fresh FCS or FCS that had been
heat-inactivated 1 hr at 56°C.

The following FCS concentrations were

employed: 1%, 5%, 15%, and 30%.

The cells were fixed after 8 days of

treatment with calcium-buffered formalin as described in the dose and
time dependence experiments.

The coverslips were stained with oil red

0) counterstained with hematoxylin. and scored for the extent of oil

red 0 positive staining as described in Research Section I· (Fig. 1).
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Comparison of E600 and p-Nitrophenol:

Normal.cells (GM-179) .were

seeded on.coverslips in culture dishes.asdescribed in the dose and
time dependence experiments above.

Cultures

wer~

grown in MEM

supplemented with.15% heat-inactivated (1 hr at 56°C) FCS and varying

.

-4

concentrations of E600 (10

-4-3

M, 3 x 10

M, 10

-4M, 3 x 10-4 M, 10-3M, 3 x 10-3M).

M) or p-nitrophenol

After 2 days treatment, the

(10

cells were fixed with calciumrbuffered formalin as described in the
dose and time dependence experiments.

The covers1ips were stained

with oil red 0, counterstained withhematoxyl1n, and scored for the
extent. of oil. red 0 s taini:ng as· described in Research Section I (F.ig. 1).

To estimate toxicity, 5 Chartpak squares, whose approximate area was
2

2.58 mm

each, were placed on each coverslip, the number of cells per

square were counted and used to calculate the number of cells per
coverslip.
Neutral Red Staining:

Normal cells (GM-179, GM-37)

t

Wolman's disease

cells (GM-1606) , Wolman's disease.heteroz:ygote cells (GM-2l2l, GM-3557
(M»·, and Bloom's syndrome cells (GM-2548) were seeded on coverslips in

culture dishes as described in the dose and time dependence experiments.
Untreated cells and cells treated with lO-4M E600 for 9 days were
stained 30 min in 0.005% neutral red (filtered before use) and scored

for the number of positive-staining granules as described for oil red 0
staine~

granules in Research Section I

Effect on Bacterial Growth:

(~ig.

1).

Each of 2 tubes containing 10 m1 of trypticase

soy broth was inoculated with 0.3 m1 of Escherichia coli cultured WP ,
2
a strain which requires tryptophan.

One tube was treated with IO-3M

E600, the control tube with 0.5% ethanol.
aeration for approximately 2 hr.

The.tubes were incubated with

The optical densi.ty was read on a
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Spectronic 20 (Bausch & Lomb) at intervals.

When the optical density

of the control reached 0.42, dilutions of both tubes were prepared in
Puck's balanced salt solution (PBS).

Triplicate pour plates in brain

heart infusion .agar were prepared at the 10-6 ,10-7 ,and 10-8
of the control, and at the 10
E600-treated tube.

-5

dilutions

-6
-7
-8
,10 ,10 ,and 10
dilutions of the

The plates were incubated at 37°C for 2 days and

counted.
Results
Paraoxonase Inactivation:

FCS showed

~ignificantparaoxonase

activity

which increased linearly with the concentration of FCS (Fig. 13).
the 'FCS at 56 ° C reduced paraoxonase activi ty (Fig. 13).

Heating

There appeared to

be a significant percentage of paraoxonase activity that was resistant
to

heat~ng

at 56°C (Fig. 14).

abolished much of'this activity
effect on FeS
:!.

Growth Curve:

~paraoxonase

However, heating at 70°C for 10 min
(~ig.

13).

Gamma irradiation had no

activity (Fig. 15).

Growth was not inhibited by either lO-5M or lO-4M E600.

At lO-3M E600 both normal and Wolman's disease cultures showe~ growth
inhibitioIl (Figs. 16,17).

Wolman's disease cells appeared to be somewhat

more susceptible to E600 than normal cells.

The trypan blue viabilities

were comparable, except on day 12 and 16 of Fig. 16, in which the E600treated GM-2l09 (P) cells showed less viability than the untreated cells.
Relative Toxicity:

There was little difference between the normal cells

and Wolman's disease cells in sensitivity to E600.

normal cells

app~ared

After 2 days the

to be slightly more susceptible than the Wolman's

disease cells (Fig. 18).

The 1D50 for GM-179 was calculated to be 0.7

DiM E600 and the IDSO for GM-1606 was 0.95 mM.

However, by 6 days the

situation was reversed, as the Wolman's disease cells exhibited slightly

· 34 ..

more

inhibit~on

that.the normal.cel1s (R!g. 19) • . The 1DSO for GM-179

now measured 0.4

~~

and the ID50 for GM-1606 was 0.24 mK E60Q,

Dose. and Time Dependence:

A conspicuous increase in lipid

sto~age

in

cells exposed to E60D was noted in both normal cultures, GM-37 (Fig. 20)
and GM-316

(~ig.

21).

After seeding, 10 to 24% of the untreated normal

cells exhibited low levels of lipid storage. This proportion increased
to as much as 80% with increased time in culture.

However) the extent

of lipid storage never approached the level seen in cells treated with

lO-4M E60D or untreated Wolman's disease cells.

Normal cells treated

with IO-6M E600 showed an extent of lipid storage similar to that of
time-matched controls.

Altho~gh

culture GM-37 appeared to show some

lipid storage after treatment with IO-5M E600, the GM-316 culture did
not clearly express lipid storage until treated with IO-4M E600. At this
concentration very little time-dependent increase in lipid accumulation
was observed.

Normal cells treated with 3 x IO-4M E600 showed a slight

increase in time-dependent lipid s tor.age, whereas cells treated wi th
lO-3M E600 showed a pronounced time-dependent build-up of lipid.

At

3 x lO":"3M, some lipid stor.age was observed, but the cells died within

4 days.

All cells were killed by 10-1M E600 within 12 hr.

Untreated Wolman's disease cells showed a more marked lipid accumulation

than normal cells with time in culture after seeding (Fig. 22).

The

extent of lipid already present in the cells made it difficult to detect
inCl"eased lipid stor.age in treatment with 10

-4M and 3 x 1.0-4M E600.

However, at lO-3M E600, an increase in lipid accumulation was evident.
-3
When cells that had been treated with 10 M E600 for 12 hr to 4
days were removed from E600 and grown in normal media, the levels of

stored lipid dropped,

approac~ng

those of untreated cells

(~igs.

20,21).

Generally, the
the lipid

l~nger

sto~age.

cells had ,been treatedtthe longer it took to reverse

GM-37 cells treated for 12 hr required more than

1.5 but less than 3.5 days to return to controls levels.

GM-37 cells

treated 1 day took more than 3 but less than 7 days, whereas cells treated
for 4 days had not reached control levels 9 days after removal of E600.
The GM-3l6 culture appeared to reverse lipid storage more rapidly than
the GM-37 culture.

GM-316 cells treated 12 hr returned to control levels

12 hr later and those treated for 1 day returned to control levels within
3 days.
Histochemistry:

Refractile granules were observed by phase contrast

microscopy in the cytoplasm of all fixed, unstained Wolman's disease
cell cultures as well as in normal cultures treated with 10-3M E600 (Fig.

23). Crystalline inclusions were also visible-in all but the untreated
controls.

Similar inclusions were observed in unfixed cells.

Like untreated Wolman's disease cel1s, normal cells treated with
lo-1M E600 showed the presence.of neutral lipid, as evidenced by positive
staining with oil red 0, sudan black B, and nile blue sulfate (Table

3).

The oil redO positive lipid was pyridine extractable.

Both E600-

treated normal cells and untreated WoLman's disease cells gave intense
staining for cholesterol, both by the perchloric acid naphthoquinone
and Schultz reactions.

The Wolman's disease cells did not stain by Schnabel's

procedure for differentiating cholesterol and cholesteryl esters by which
o11ly free cholesterol stains.

The E600-treated cells, both normal and

Wolman's disease, showed a small number of positive granules.

This indicates

that both WoLmants disease and E600-treated cells stored a large amount
of cholesteryl ester, and that the E600-treated cells also stored a small
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TABLE" 3

HISTOCHEMISTRY OF NORMAL AND WD CELLS, UNTREATED AND TRElTED VITH 10- 3M £600
Staining
technique

Substance
Sta hed

Norllat cells

WO cells

Stain Intensity of Cytoplasmic: Cranules
E600-treated normal cells
E600-treated VO cells

0

++++

+t+t

0

++++

++++

++++

0

0

0

0
+

++-fA

.......

.......

+

+

+

unsaturated lipid

0

0

Copper phthalocyanin
tfolcz1nger S copperrube.nfc acid

phospholipid
free fatty acid

.b

.b,c

..b.d

++btd

.'

+1

..'

++1

Schultz method

cholesterol. cholesteryl
esters
cholesterol, not
cholesteryl esters

0

+++f

+++1

+++f.9

0

0

+

•

0

•••

++++

++++

+

.+++

++++

Sudan black B

Lnl1.'s oil red 0
Pyridine extraction.

ofl red 0
Clfn's Nile blue
sulfite

lorton's bromines11ver
Performic acid-

neutral lipid.
phospholipid
neutral lipid
non-lipid. 011 red
o + material
neutral lipid (red)
acidic lipid (blue)
unsaturated lipid

0

Schiff

I

Schnabells differen-

tiation of Schultz
_thad
"AdIIll'S perchloric
actd-naphthoqui none
Auton uorescence
Periodic acid-Schi ff
(PAS)

cholesterol, cholesteryl
esters
glycolipid, glycogen,
mucosubstance
(cytoplasmic matrix/
granules)

+ to ++/
Oto +, +++h

same as above

PAS-Diastase
'el"llll.nganate.1dehyde fuchsin
6oIIIor1 's esterase
pit 7.4
_ri's esterase

probably lipofuscin

+

to

o to

++/ •
+~++'

same as above

o,++~

0

++/0 to+
same as above
0

non-specific esterase

o to

+

o to

+

o to +

non-specific esterase

o to

+

o to

-+

o to +

+++/0 to +

saale as above
0

pH S.Q

Aldehyde fuchsin.1cian blue
A1cian blue, pH 2.5PAS

Aleian blue. ph 2.5
Alcian blue. pH 1.0

sulfated (purple),
carboxyl (blue)
mucosubstance
neutral (magenta), acidic
{blue-purple;
mucosubstance
acidic mucosubstance
sulfated mucosubstance

0
+k

0

0
+. . . i,k

.k

.k

0

0

0

0

0

0

0

0

tee1)s stained pink indicating presence of neutral lipid. E600-treated celts showed pink cytoplasmic staining and pink-staining granules. wftere.5
WOllin's disease cells only showed the latter.
bNuelei and nucleoli stain.
CGH-221l showed some small dark staining granules in cytoplasm.
dOIrker staining in perinuclear location. possibly representing Golgi zone.
'Nucleoli stain.

'WOlman'S disease cells showed small to medium-sized. blue-green granules. E600-treated cells showed gray-green granules, some of which were quite
large.
'£xOCytosis of lipid granules was visible.
~37

showed strong staining around large cytoplasmic granules.

tGM-2211 snowed many small PAS-positive granules.
jGM-2109 showed small PHAF-posittve granules throughout cytoplasm.

kcytoplls-ic

~trix

stained with PAS as 5bove. nuclei stained with alctan blue.
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but definite amount of unesterified cholesterol.

Untreated Wolman's

disease cells and E600-treated normal cells were both highly
autofluorescent (Fig. 24).
Holczinger's fatty acid stain was weakly positive for nonnal and
Wolman's disease cells and somewhat more strongly positive for E600-treated
cells.

In both the nile blue sulfate and fatty acid stains, the

reactivity in the E600-treated cells appeared to include staining that
was not associated with granules.
for phospholipid

sta~ed

The copper phthalocyanin procedure

a perinuclear region of E60D-treated cells that

may have represented the Golgi zone.

The GM-2109 (P) Wolman's disease

culture, but not Wolman's disease culture GM-1606, was positive for the
perm~nganate-aldehyde

fuchsin stain.

to lipofuscin-like material (62).

This stain is thought to be reactive

Neither untreated nor E600-treated

normal cells showed any reactivity to permanganate-aldehyde fuchsin.
The presence of lipofuscin-like material may be related to the early
senescence of the GM-2l09 (P) culture.

No difference in reactivity was

observed among controls, Wolman's disease cells, and E600-treated cells
.

for unsaturated lipid, glycolipid, or "mucosubstance.
of the Wolman's disease cells treated with 10

.

The stain reactivity

-3
M E600 was comparable

to

that of the similarly treated normal cells, although somewhat more
intense in the former.
Comparison of Wolman's Disease Cell Cultures:

There was considerable

variation in the amount of oil red 0 positive lipid stored by the 3
Wolman's disease cultures (Fig. 25). Culture GM-1606 showed little to no
lipid accumulation when first obtained, but after approximately 3 months
in culture significant lipid accumulation was observed.

Culture GM-22l1

and GM-2109 (P) both exhibited lipid accumulation from the time they were

· 38
obtained.

Culture GM-2l09 {P} stored the most lipid,; grew the slowest, and

reached senescence after only approximately 18 population doublings.
No significant differences were seen in the amount of oil red 0
positive lipid stored by the GMr2211 Wolman's disease culture before
and after trypsinization (Fig. 26).
Lipid Addition:

Increased lipid

sto~age

was seen in normal cells treated

with 4.0mg% cholesterol, but no lipid storage was seen at lower
concentrations or in Wolman's disease cells (Fig. 27).

Treatment with

free fatty acid resulted in increased lipid storage in both normal and
Wolman's disease cells at concentrations of 0.04 mg% and 0.4 mg% (Fig. 27).
More lipid was stored at the

~igher

concentrations.

concentration, 4.0 mg%,was toxic to the cells.

The highest

In hoth treatment with

cholesterol and free fatty acid, the observed lipid storage differed

from

that seen in Welman's disease or E600-treated cells.

The lipid droplets

were

No change in lip~d

l~rger

and located more peripherally (Fig. 28).

storage was seen after treatment with cholesteryl ester.
Effect of Serum Concentration and Inactivation:

The amount of lipid

stored in normal cultures treated with 10-3M E600 varied directly with
the concentration of serum in the medium (Fig. 29).
concentrations, the

cell~

At higher serum

grown in heat-inactivated serum appeared to

store more lipid than those grown in fresh serum.
COmparison of E600 and p-Nitropheno1:

p-Nitropheno1, the major metabolite

of E600 (35,36), appeared to have little effect on the induction of lipid
storage (Fig. 30).

When the concentration of 10

-3

~M

p-nitrophenol was

reached, lipid accumulation became noticeable, but at this concentration
less than half of the cells sterad lipid, whereas 90% of cells treated
with lO-4M E600 sho~ed lipid accumulation.

p-Nitrophenol appeared to be

slightly more toxic to the cells than E600 (not shewn).

39

TABLE 4

MEAN COLONIES OF E. COLI PER PLATE, UNTREATED AND TREATED WITH IO-3M

E600. a

E600-TREATED

DILUTION

CONTROL

10-8

7.7

1.7

10- 7

65.0

23.3

10- 6

537.7

217.0

Mean

6.52 x 10

8

2.06 x 10

8

aE• coli stain WP2 treated with 10-~ E600 or 0.5% ethanol for
controls were grown in trypticase soy broth for approximately 2 hr
-8
-7
-6 dilutions were pour plated
with aeration, and 10 ,10 , and 10
in brain heart infusion agar, incubated at 37°C and counted 2 days·

later.

~lgure

13.

Paraoxonase

activ~ty

inactivated for varying amounts of time.

of.fetal calf serum heat(A)

0 hr, 56°Cj

(B) 0.5 hr, 56°C; (C) 1 hr, 56°C; (D) 2 hr, ·56°Cj (E) 10 min, 70°C.
Increased heati.ng time "resulted in a decrease in paraoxonase activity.

Figure 14.
56°C.

Paraoxonase activity of fetal calf.serum heated at

S.ignificant activity

l*las

resistant. to heating at 56°e' indicating

the presence of two enzymes with paraoxonase activity.
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15.

Paraoxcnase activity of fetal calf serum exposed to

gamma irradiation or heating.

(A) 0

~..r';

(B) ,25 kr; (C) 50 kr;

(D) 100 kr; (E) 200 kr; (F) heated at 56°C for 2 hr; (G) heated at

70°C for 10 min.

Gamma irradiation, unlike heating. did not affect

paraoxonase activity.
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16.

Growth curve of (A) SaJo, normal, and (B) GM-2109 (P),

Wolmm\'s disease cells, untreated (oEl) and treated with lO~3M E600

(ell).
cells.

E600-treatment was more toxic to Wolman's disease than to normal
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17.

Growth curve of (A) G.M-179, normal, and (B) GM-1606,

Wolman's disease cells,untreated (OEl) and treated with IO-3M E600

(ell). E600-treatment
to normal cells.

was

s~ightly

more toxic to l-lolman's disease than

In points without error bars, ,the error bars fell

within the outlines of the point.
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18.

Toxicity of E600 .to (A) GM-179, normal t and (B)

GM-1606, Wolman's disease cells treated .for 2 days with
concentrations of E600.

E600 appeared to.be

s~ightly

vary~ng ·

more toxic

to normal cells than to Wolman's disease cells.

Figure 19.

Toxicity of E600 to (A) GM-179 , normal, and

(B) GM-1606, Wolman's disease cells treated for 6 days with
varying concentrations of E600.

E600 appeared to be slightly more

toxic to Wolman's disease than to normal cells.

after 6 days than after 2 days

(~ig.

18).

E600 was more toxic
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Dose and time dependence of E600-induced lipi.d

,accumulation in GM-37,normal.cells and its reversibility.
cells per box were: graded for the extent of oil red 0
accord~ng

to

th~

One hundred

positiv~

granulation

grades shown in Fig. 1 (A) control, exposed to 0.5%

ethanol; (B) lO-6M E600; (C) lO-.5 M E600; (D) lO-4 M E600; (E) 3 x lO-4M E600;
(F)" IO-3M E600; (G) IO-3M E600, 12 hr, untreated thereafter; (H) IO-3M E600,
24 hr, untreated thereafter, (I) IO-3M E600, 48 hr, untreated thereafter;
(J) lO-3M E600, 4 days, untreated thereafter.

GM-37 cells showed

time-dependent increases in li.pid .storage which were minimal at lO-4M
.
-3
-3
E600 and pronounced at 10 M E600. (G-J) cells were trea ted wi th 10 M
E600 for the specified period, rinsed with Puck's balanced ,salt solution
and incubated in medium contami:ng 0.5% ethanol until fixation.

After

removal of the E600, the cellular lipid accumulation returned to control
levels (A).
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21.

Dose and time dependence of E600-induced lipid

accumulation in GM-316, normal cells and its reversibility.
cells per box
accord~ng

wer~

One hundred

graded for the extent of oil red 0 positive granulation

to the grades shown in

~ig.

1.

(A)

control, exposed to

0.5% ethanol; (B) lO-6 M E600; (C) lO-5M E600; (D) lO-4M E600; (E) 3 x lO-4M

E600; (F) IO-3M E600; (G) 3 x IO-3M E600; (H) IO-3M E600, 12 hr, untreated
thereafter. (I) lO-3M E600 t 48 hr, untreated thereafter. GM-316
cells showed time-dependent increases in lipid storage which were
-4
.
-4
-3'
minimal at 10 t1 E600 and more pronounced at 3 x 10 M and 10 M E600.
-3
Toxicity was observed at 3 x 10 M E60D. (H,I) Cells were treated with
. -3
.
10 M E60D for the specified period, rinsed with Puck's balanced salt
solution and incubated in medium containing 0.5% ethanol until fixation.
.

.

After removal of the E600, .the cellular lipid acctmlulation returned to
control levels (A).
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22.

Dose and time dependence of E600-induced lipid

accumulation in GM-1606, Wolman's disease cells.
per box

wer~

according to

graded for the extent of oil red 0
th~

grades shown in

~ig.

1.

One hundred cells.
positiv~

granulation

(A) control, exposed to

0.5%' ethanol; (B) lO-6M E600j' (C) lO-5 M E600; (D)

lO-4~f E600;

(E) 3x lO-4M E600; (F) IO-3M E600; (G) 3 x IO-3M E600.

Untreated ~ells

showed pronounced lipid accumulation with increased

in .

culture.

t~e

Further increases were seen in cells treated with IO-3M
-3#
and 3 x 10 M E600, tho.ugll the latter concentration was toxic to the

cells.
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Figure 23.

Lipid droplets and crystals in the cytoplasm of

Wolman's disease and E600-treated normal cells. (A) GM-179, normal,
untreated; (B) GM-1606, Wolman's disease; (C) GM-2211, Wolman's disease;
(D) GM-2109 (P), Wolman's disease;

E600.

(E) GM-179, normal, treated with lO-3M

Cells were fixed in calcium buffered formalin and observed by

.phase contrast microscopy_

~ig~re 24.

X260.

Autofluorescent lipid in. the cytoplasm of' Wolman t

disease and E600-treated normal cells. (A) GM-37, normal,
-3
.
untreated; (B) GM-37, normal, 10 M E60D for 7 days (C) GM-2211,
Wolman's disease, untreated.

X200.

s
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Extent of lipid

cell cultures and a normal control.
graded for the extent of oil red 0
grades shown in
dis~ase,

~ig.

1.

sto~age

in different Wolman's, disease

One.hundred cells per.box were
positiv~

granulation

accord~ng

to the

(A) GM-179, normal; (B) GM-1606, Wolman's

2 months in culture; (C) GM-1606, Wolman's disease, 3 months

in culture; (D)

~1-22ll,

Wolman's disease, 2 months in culture; (E) GM-2109

(P), Wolman ' s disease, 8 months in culture. Culture GM-1606 did not
accumulate more lipid than normal cultures until in culture for 3 months.

~igure

26.

Lipid storage in GM-2211, Wolman t s disease cells

(A) .before and (B) after trypsinization.

One hundred cells per box were

graded for. the extent of oil red O. posi.tiv~ granulation according to the
grades shown in Fig. 1.
on lipid storage.

Trypsinization appeared to have little effect
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27.

Lipid

sto~age

in GM-498, normal (A,B,C) and GM-1606,

Wolman's disease (D,E,F) cells treated with varying concentrations of
cholesterol (A,D), cis-vaccenic acid (B ,E), and cholesteryl palmitate',

(C,F).
red 0

One hundred cells per box were graded for the extent of oil
positiv~

granulation according to the: grades shown in Fig. 1.

Cis-vaccenic acid at 4.0 ,mg% was toxic to the cells. (The O.concentr.tion

values are the means of

th~

grades of'300 cells for each culture.)

-.--50'

CONCENTRATION (mg% )

o

0.04

50

50

50

50

E

50

F
50

GRADE

0.4

4.0

~igure

28.

Lipid storage in GM-498, -normal and GM-1606, Wolman's

disease cells treated with varying concentrations of cholesterol, free
fatty acid, and cholesteryl ester.

(A) untreated; {B}4.0 ,mg% cholesterol;

(C) 0.4 ,mg% cis-vaccenic acid; (D) 4.0 mg% cholesteryl palmitate.
Normal cells treated with cholesterol or free fatty acid and Wolman's
disease cells treated with free fatty acid exhibited large peripheral
lipid droplets.

Stained with oil red 0 and hematoxylin. ,X500.
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29.

Lipid. storage

j.n G~I-316,

normal. cells trea ted with

IO-3M E600 in the presence of vary~g concentrations of fetal calf . serum.
One hundred cells per box
positive granulation

wer~

accord~ng

graded for the extent of oil red 0
to the grades shown in Fig. 1.

(A) fresh

fetal calf serum; (B) fetal calf serum heat-inactivated 1 hr at 56°C.
E600-induced lipid accumulation varied directly with the serum concentration,

~igure

30.

Lipid

sto~age

in cells of normal culture GM-l79

exposed to identical concentrations of (A) E600 and (B) p-nitrophenol.
One hundred cells per box
positiv~

th·~ugh

wer~

graded for the extent of oil red 0

granulation according to the grades shown in Fig. 1.

less toxic than p-nitrophenol, produce.d

accumulation.
coverslip.

E600,

significantly more lipid

Results for the untreated control were from the same
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31.

Neutral red

-4

stain~ng

untreated and treated with 10 M E60D.
wer~

of various cell cultures,
One hundred cells per .box

graded for the extent of neutral.red granulation according

to grades corresponding to those shoy."11 for oil redO staining in
~ig.

1.

(A) GM-37, normal; (B) GH-179, normal; (C) GM-2548, Bloom's

syndrome; (D) GM-3557, mother of proba.nd; (E) GM-1606, Wolman's

disease.

E600-treatment resulted in increased neutral red granulation.

. 53
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~igure

32.

Neutral red

stain~ng

of various cell cultures,

untreated and treated with lO-4M E600.

(A) GM-37, normal; (B) GM-179,

nOl~mal;

Clear granules are also visible

(C) GM-1606 , Wolman's disease.

in the E600-treated cells.

E60o-treatedcells.

X42S.

A clear. perinuclear area is visible in the,
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Untreated

E600-treated

F,igure 33.

Neutral red

stain~ng

heterozygote cell culture, GM-2121.
for the extent of
correspond~ng

neutral.re~

of a Wolman IS disease

(A) One hundred cells were graded

granulation according to grades

to those shown for oil red 0

. (B) Linear arrangement of neutral

re~

stain~ng

in Fig. 1 .

granules •. X570.

The GM-2I21

cell.culture had more neutral red granules than other untreated cell
.cultures

(~igs.

31,32).

Clear granules are also visible.
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A

· 56,

~eutral

Red Staining:

Wolman's disease cells did not show more neutral

red granules than normal cells (F.igs. 31,32).

an increased number of neutral red granules.

E600-treated cells showed
E600-treated cells, both

normal and Wolman's disease, also exhibited clear granules that did not
stain with neutral red (Fig. 32).

The GM-2l21 culture showed more neutral

red granules than the-other untreated cultures, and the granules appeared
to be arranged linearly (Fig. 33).
Effect on Bacterial Growth:

in Table 4.

The number of colonies per plate are shown

When the results from each concentration were averaged together,

the untreated E. coli tube was calculated to number 6.52 x 108 organisms per
m1 whereas the E600-treated tube showed only 2.06 x 10

8

organisms per mI.

At the time the tubes were plated, their respective optical densities were
0.42 and 0.26.

Discussion

The shape of the curve for paraoxonase inactivation (Fig. 14)
s,uggests that FCS contains two enzymes wl.th paraoxonase activity which can
be separated on the basis of their sensitivity to heating (31,32).
paraoxonase activity of
at 56°C for 1 hr.

Fes

The

can be reduced to less than half by heating

Because further heating produced only a slight reduction

of paraoxonase activity but could have had effects on other factors
necessary to cell growth, FCS was inactivated for 1 hr at 56°C in
experiments in which cells were treated with E600.

Heat inactivation did

not result in decreased, lipid storage (Fig. 29).

In fact, a slight increase

in lipid storage was seen, presumably due to the maintenance of a higher
E600 concentration in medium with heat-inactivated serum.

-5
-4
No evidence for E600 toxicity was seen at 10 M or 10 M E600 in the
growth curve,· although the relative toxicity experiment showed some inhibition
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at lO-4M E600. by day 6. .At

lO~3M E600 both th~ growth curve and the

relative toxicity experiment showed
time of exposure resulted in

some.toxic~ty-to

~ncreased

cells.

Increased

toxicity in both experiments.

Typically the extent of cell toxicity is proportional to the test
concentration and the duration of incubation (63).

Wolman's disease cells

appeared to be slightly more susceptible to E600-induced killing than
normal cells (Figs. 16,17,19).

Wolman's disease cells, because they are

deficient in acid lipase, might be expected to rely more on other enzymes
that are sensitive to E600.

However, the lack of any significant toxicity

at 10-5 M and 10-4M E60D, concentrations that should completely inhibit most
esterase enzymes (27), makes this hypothesis less likely. It is possible
that cytoplasmic enzymes are exposed to a lower concentration of
E600 than the lysosomal enzymes, because lysosomes fuse with phagocytic
vacuoles which may carry E600 into the cells.

Perhaps the lip'id storage

already present in Wolman's disease cells caused

the~

to reach' toxic levels

of lipid sl.ightly before the E600-treated normal cells.
affected by organophosphates like E600 (38,64).

Respiration may be

Because the Wolman's

disease cells are already under stress due to their enzyme deficiency, they

may show a decreased ability to resist other stressful stimuli.
E600 appeared to be quite toxic to bacteria.

The tube grown without

-3
E600 showed 3. 2 times as many viable o,rganisms as the tube with 10 M E600.
The optical density, which shows the live and dead organisms, showed only
1.6 times as many cells in the untreated tube.

This discrepancy could

be explained if the E600-treated tube contained 2.06 x 10
organisms and 1.98 x 10

8

dead o.rganisms.

8

viable

Because the tubes were incubated

for only 2 hr it is unlikely that the E600 had degraded sufficiently to
cause an increase in optical density.

It is unclear whether the growth
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inhibition is due to bacterial dependence upon lipase or esterase activity
for growth or an effect of E600 on bacterial respiration.
The wide variation seen in the amount of lipid stored by the 3
Wolman's disease cultures (Fig. 25) may indicate different levels of
residual acid lipase activity, but it may also reflect the different growth
rates of the 3 cultures.

When the GM-l606

WoL~an's

disease culture was

first obtained, it proliferated rapidly and exhibited little lipid
accumulation for about 2 months.
pas~age

After 3 months, in cells of a similar

level, the growth rate had slowed and lipid accumulation was

noticeable and has continued to be since.

Kyriakides

~

ale (42) also

obsented a Wolman's disease fibroblast culture that did not store lipid
until it had been in culture 3 months.
slowes~ grow~ng

The GM-2l09 {P} culture was the

Wolman's disease culture and it accumulated the most lipid.

After only 18 population doublings, the cells exhibited the typical.
characteristics of a senescent culture including lower growth rate, low
density, and large cells (Fig. 23), which Kontermann and Bayreuther have
called type II fibrocytes (65).

It is not known whether or not the

presence of large amounts of stored lipid may shorten the lifespan of a
fibroblast cell culture.

In actively growing cultures there are fewer non-

proliferative cells, and the short generation times and the rapid formation
of,new cytoplasmic material in the proliferative cells may have the effect
of diluting the stored lipid.

The rapidly proliferating cells have a high

metabolic activity as well, and may be able to utilize more lipid for energy
or membrane biosynthesis,.

Thus lipid storage may not be 111B.nifested as

clearly in the rapidly proliferating cells.

Regular subcultivation and

other culture conditions may be important in determining the degree of
expressivity of this mutation in vitro.

The lipid stored in cells treated with free fatty acid was probably
t~iglyceride

and phospholipid (66,67).

Storage may have increased more in

the Wolman's disease cells than in the normal cells.
to be true in cells treated with choles terol.

The reverse appeared

The Wolman's disease cells

may require more cholesterol for membrane synthesis because they cannot
obtain cholesterol from cholesteryl ester.

The normal cells, therefore,

may be experiencing a greater effective concentration of cholesterol
because they have less use for the cholesterol and are also still
metabolizing cholesteryl esters.
esterification of the cholesterol.

This may result in cytoplasmic
The morphological difference between

these cells and E600-treated cells may result from tile difference between
cytoplasmic and lysosomal stor.age of lipid.

Cholesteryl ester is normally

taken up as a component of low density lipoprotein (LDL).

The lack of

lipid 'storage in cells treated with cholesteryl ester was most likely due
to the form of the lipid.

If isolated LDL had been added, the result would

probably have been quite dif!erent (9).
Some of the crystals seen in Wolman's disease and E600-treated
normal cells were most likely cholesteryl ester, but some may also
represent triglyceride that had been crystallized by formaldehyde fixation
(68).

Cholesteryl ester crystals have also been visualized by electron

microscopy in cultured Wolman's disease cells (Research Section IV) and
tissue from Wolman's disease patients (16,69, 70).

The autofluorescent

granules seen in the Wolman's disease and E600-treated normal cells were
probably lipid.

It is not clearly established whether or not neutral

lipids or free fatty acids are fluorescent (71-73).

Various oxidized

derivatives of neutral lipids are believed to be fluorescent (74-76)
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and fluorescence is a fundamental cha}:'acteristic.o£ lipofuscin and ceroid.
Oxygenated steryl.esters (77) and ceroid (78) havebeen.reported to be
present in tiasues from Wolman's disease patients$ but the reported
Partin & Schubert (79)

lipids have not been shown to,be autofluorescent.

reported autofluorescent foam cells in an intestinal biopsy from a patient
with cholesteryl ester storage disease.
Wolman's disease and E60D-treated cells

The autofluorescence we saw in
n~y

be due to oxidized and

peroxidized lipids or to the low grade fluorescence from large accumulations
of

cholesteroiL~

fatty acids, and tr.iglyceride (71).

E60D-treated cells were quite similar to Wolman ':s disease cells
histochemically.

Both showed large amounts of neutral lipid and

cholesteryl esters.

Beth did not differ from controls in staining for

mucosubstance, glycogen, or unstaturated lipid.

However, the E600-treated

cells showed slight increases in free fatty acid, free cholesterol, and
perhaps phospholipid which were not observed in Wolman's disease cells.
The E600-treated cells may resemble Wolman's disease cells because they
have deficient acid lipase (Research Section III), but if so, they
probably have reduced activity of other enzymes as we11.
The lipid stored in E600-treated cells was derived from serum, an
expected finding for cultured cells (9,66,67,80), and much of it appeared
to be cholesteryl ester.

Goldstein et a1. (9,80) have shown that

cholesteryl esters are taken up as a component of LDL at a
LDL receptor and are degraded in the lysosomes.

spec~fic

The free cholesterol

generated leaves the lysosome and exerts several regulatory actions,
including the suppression of the synthesis of LDL receptor molecules
and the resultant reduction of the amount of LDL taken up.

In

acid lipase deficient cells (Wolman's disease and cholesteryl
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estersto~age

disease), . the cleayage o{.cholesteryl esters is reduced,

so no free cholesterol is
receptor synthesis.

formed.result~ng

in no inhibition of LDL

Under these conditions, the cell continues to take

up large amounts of LDL-cholesteryl esters.

The

sto~age

of cholesteryl

esters in E600-treated cells may have a similar mechanism.
-6
-5
Treating cells with 10 M and 10M E600 appeared to have little

effect on them, but ,at lO-4 M E600 definite lipid accumulation was observed.
This concentration of E600 had little toxicity.
same concentration, had no apparent effect.

p-Nitrophenol, at the

Cells treated with 10-4M

and 3 x lO-4M E600 showed little pr.ogressive build-up of lipid with time,
s.uggesting that at these concentrations enzyme inhibition and lipid
"

storage were balanced by E600

~egradation,

and the synthesis of new enzyme.

At

the metabolism of stored lipid,

lO-~M E600 this balance w~y have

been upset, for a more progressive time-dependent accumulation of lipid
was observed.

Although E600 is somewhat toxic to the cells at this

concentration, this is probab.ly not related to the lipid storage.
p-Nitrophenol, at the same concentration, is slightly more toxic, but
has much less effect on lipid storage •. Although p-nitrophenol has been
reported to be significantly more toxic than E600 (35,36), if the authors
had measured the concentration in molarity rather than parts per million,
the results would have been different.

There would have been no difference

in toxicity to fibroblasts, although p-nitrophenol would still have been
more toxic to HeLa cells.
The reversal of lipid accumulation that occurred when E600 was removed
from the medium was probably due in part to the synthesis of new enzyme
(37) and in part to the slow return of activity to inhibited enzyme (81).
The return of activity may be caused bv hydrolysis of the phosphate group
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transferred t,o a .functional site of -the enzyme by E600
(81). Two

ethy~

groups are attached to the transferred

dur~ng

iuactivation

phospbat~

group

in E600-induced enzyme inactivation and the return of activity is, quite
slow, but with. d;i.methyl p-nitrophenyl phosphate, which has 2 methyl groups
attached to the phosphate, the rate of hydrolysis is more rapid (81).
Neutral red granules are believed to be lysosomes (82,83).

The

GM-1606 Wolman's dis-ease culture which was at an early passage level,
showed the same ntmlber of neutral red granules as the normal cells.
However, the GM-221l culture, which stored more lipid, appeared to have
increased neutral

re~

granules in an earlier assay.

It may be that the

.age a.nd c011dition of the culture, cell density, FCS c.oncentration and
variation between FCS lots may be more important in determining the number
of neutral red granules in a culture than the presence of a lysosomal
enzyme'deficiency.

However, the fact that E600 treatment consistently

resulted in a significant increase in the number of neutral red granules
suggests that the presence of, a large amount of stored lipid in the lysosomes

may

s~imulate

cells to increase the formation of lysosomes.

Typically,

lysosomal storage diseases show increases by biochemical assay of some
lysosomal enzymes other than the deficient one (17,84,85).
neutral red granules may be a

morpho~ogical

Increased

reflection of this, representing

an attempt by the cells to clear the stored material and, if the material
interfered with normal degradation, to maintain sufficient operational
lysosomes.

The granules not stained by neutral red

tl~t

were observed

in the E600-treated cells are structures that are not at acid pH and

may represent non-lysosomal lipid

sto~age,

lysosomal bodies that have

lost their acid pH, perhaps due to the buffering action of storage products,
or vacuoles unrelated to lipid storage.

The linear

arr~ngement

of neutral

.63.

re~

granules .apparent

cultures

s.~ggests

~n

the

G~~2121.cultuxe.and

that lysosomes

may

hinted.at in other

be'~rganized

by microtilaments,

microtubules, or other structural components of the cell.

RESEARCH SECTION III

Introduction
The similarity of the histochemistry of E600-treated cells and
Wolman's disease cells shown in Research Section II suggests that E60D
(diethyl p-nitrophenyl phosphate) may be inhibiting acid lipase.

E600

has been shown to inhibit porcine pancreatic lipase by transferring a
diethylphosphory~

enzyme (33).

group to a serine group at an essential site of the

The micellar concentration of E600 that inhibits

pancreatic

lipase is similar to the concentration that we have shown to induce lipid
sto~age

(86).
The histochemical results from Research Section II provided a

preliminary characterization of the lipid stored in E600-treated cells
and Wolman's disease cells.

Although the lipid stored in tissues of

Wolman's disease patients has been analyzed thoroughly (2,46,69,77,78,87-91),
analysis of fibroblast cultures has been limited (42).
Biochemical techniques such as thin layer chromatography and
gas-liquid chromatography are useful in quantitation and
characterization of the stored lipid.

mor~ specifi~

This section presents the

biochemistry of E600-,treated and Wolman f s disease cells, incl uding
attempts to assay the lipase activity present, the effect of E600
treatment of cells on acid lipase activity, and biochemical
characterization of the lipids stored.
Materirus and Methods
Acid lipase assaz:

To determine the lipase activity of normal and

Wolman's disease fibroblast cultures, cells

grown to confluency

in one 75 cnl

2

2
and one 150 cm flask were pooled and prepared

as described in Research Section

I.

Substrate was prepared as

described in 0.2 M acetate buffer, pH 4.0, but an equal amount
was prepared in 0.1 M phosphate buffer, pH 7.0 •. The assay was
performed as described in Research Section I, but the same
enzyme source was used and 40

~1

of specified concentrations

of E600 were added to the assay flasks.

In some experiments

the enzyme was pretreated with the appropriate concentration
of E600 for 30 min at room temperature. Protein was not determined

because the same enzyme source was used, and thus all assay flasks
received equal protein.
To determine the long term effects of E600 on acid lipase
2
activity, 75 cm flasks of normal cells were treated with specific
concentrations of E600 and prepared and assayed as described

in Research Section I.
!hin layer Chromatography and.Lipid Analysis:

2
Tnree 150 cm

flasks of the following cultures, whose origin is listed in Research
Section I, were grown to confluency:
GM-2121, GM-3557, (M), GM-3558 (F),
and

G~1606

were grown.

GM-49B, GM-2520, GM-207S,
and JoAl. Six flasks of GM-179, GM-37 ,
2

Only two 150 em

grew slowly, could be obtained.

flasks of GM-22l1, which

Three flasks were also grown of

normal mouse and beige mouse fibroblasts, derived from primary
abdomi.nal skin cultures of 6 week old female normal black

(C57 BL/65, +/+) and beige (C57 BL/65, bg/bg) mice.

The beige

mouse bears the trait of the Chediak-Higashi syndrane.
wer~

grown in medium with 8% FCS

of mycostatin per ml.

suppl~mented

The cells

with 100 units

Mycostatin did not appear to affect lipid

66.

storage.

Three flasks of GM-l79, GM-37, GM-1606 were treated

with lO-3M E600 whereas the other three received 0.5% ethanol.
Heat-inactivated serum was used for these flasks.

After 9 days of

treatment, the cells were washed twice in Puck's balanced salt solution
(PBS), trypsinized, and each culture was pooled in a 50 ml centrifuge
tube which was placed on ice.

The cells were counted on a hemocytometer

and the cell number' in each sample was computed.

The samples were

centrifuged at 1000-1100 rpm for 10 min on an International Centrifuge,
Model CM.

The supernatant was drawn off and the pellets were frozen

tmtil extraction.

The samples were thawed i.n 5 mlof PBS, sonicated for

15 sec on ice on a Heat Systems-Ultrasonics microtip sonicator at 50 watts
and assayed for protein by the method of Bradford (48).

5 m1 of fetal calf serum (FCS) was prepared

al~ng

A tube containing

with the other samples

after the protein was determined.
Lipids were extracted (92) in 10 ml of 1:1

chlorofor~methanol

(Fisher) and the lower chloroform layer was recovered following
cent·rifugation.

The upper layer was extracted with another 5 ml of

chloroform and this second extraction was pooled with the first.

The

solvent was evaporated with a stream of air and the lipid resuspended
in 4.5 m1 of chloroform.
The total lipid in each sample was assayed by a technique based
on the ability of lipid to reduce dichromate (93) with pooled
Paramecium lipid (l.17J.1g/ml) as a standard.
sample was

One hundred or 200 }.Ill of

added to an acid-washed tube and solvent was evaporated.

To each tube, 2 ml of acid dichromate was added (0.75. g of K Cr 0
2 2 7
was dissolved with heating in 5 ml of deionized water, cooled and made

up to 500 ml with 98% H S0 ).
2 4

Tubes

contain~ng

to 100°C in an oven or water bath for 20 min.

lipids were heated
cool~ng,

After

4.5 ml of deionized water was added to each tube with
A blank was prepared by

reduc~ng

10% Na S0 (Baker, anhydrous).
2 3

the dichomate with 0.1 mlof

The color reaction was read on a

Gilford spectrophotometer at a wavelength of 440 nm.
3 assays were

ave~aged

mix~g.

The results of

to deter¢ne the total lipid present in the

samples.
Up to 500 pg of lipid was applied to

had been heated at 120°C for 20 min

silic~

gel plates which

(Supelcosil 12At Supelco

Inc., Bellefonte, Pa.), and the neutral lipid classes were separated
by thin layer chromatography (94) in a solvent system of petroleum
ether-diethyl ether-acetic acid (80:20:0.5, Fisher).
cholesterol

(~igma),

Standards of

cis-vaccenic acid (Sigma), tripalmitin (Eastman),

and cholesteryl palmitate (Sigma) were co-chromatographed to identify
lipid classes.

After development, the plates were air-dried.

Some

were sprayed with 50% sulfuric acid (Fisher) and charred in an oven
at 100°C for 10 min to visualized the lipid spots.
were examined under

l~ng

Other plates

wave ultraviolet light and the spots were

circled and scraped into tubes.

Separate dichromate assays were

conducted for cholesterol, free fatty acid,cholesteryl ester,
triglyceride nnd phospholipid with cholesterol, cis-vaccenic
acid and cholesteryl palmitate as standards for the former three
and cottonseed oil (Fisher) as a standard for the la'tter two
lipid classes.

'llle relative percentages of E".ach lipid class

were computed for each sample and the already determined
values for total lipid were used to calculate the quantity of
each lipid class as the quantity of lipid per cell and lipid per
,mg protein.

Gas-liquid chromatography and phospholipid analysis:
2

em

Two 150

flasks of GM-179 and GM-1606 cells were grown to confluency.

One of each was treated with IO-4M E600 for 8 days.
were prepared as in the lipid analysis experiment.

The cells
Briefly,

cells were washed twice in PBS, trypsinized, pel1eted, and counted.

They were sonicated and protein was assayed.

A sample of 5 ml

of FeS was also assayed for protein.
Lipid was extracted from the 5 samples with chloroform-methanol
(l:l).and two subsequent chloroform extractions.

The neutral lipid

classes were separated on Supelcosil 12A silica gel plates and dried.

The

plates were sprayed with 2',7'-dichlorofluorescein (Eastman) and observed
by long-wave ultraviolet light.

The spots were circled and scraped into

acid-washed tubes.
Fatty acid methyl esters were prepared from the free fatty
acid,

t~iglyceride,

and cholesteryl ester fractions.

Two ml of

1% methanolic sulfuric acid and 4 drops of petroleum ether were
added to each tube.
for 18 hr.

The tubes were vortexed lightly and heated at 60°C

The methyl esters and other lipids were extracted with

2 ml of petroleum ether after the addition ofl ml of water.
The petroleum ether (upper) layer was pipetted into a clean tube.
The original tube was extracted with another 2 ml of petroleum ether
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and the upper layer was pooled with.the

fi~stextract.

The solvent

~l

of petroleum

was evaporated and the samples were dissolved in 50
ether and spotted on Supelcosil 12A

silic~

gel plates.

The plates

were developed in petroleum ether-diethyl ether-acetic acid
(80:20:0.5) and dried.
m~thyl

fluorescein, the
clean tubes.

After spraying the plates with 2',7'-dichloroester spots were circled and scraped into

The methyl esters were extracted with 4 ml of chloroform-

methanol (1:1) and one drop of water.
centri~uged

to

br~g

into a clean tube.
from each sample.

down the

silic~

The tubes were vortexed,
gel, and the extract was poured

This was repeated twice, pooling the extracts
The solvent was evaporated under a stream of air.

Fatty acid methyl esters were analyzed by gas chromotography on a
Hewlett-Packard flame ionization 5711A gas chromatograph

fitted with a

50 meter x 0.5 mm glass wall-coated open-tubular column coated with
Apolar-5CP (Applied Science Corp.).

The conditions were:

temperature l80oC, injector 250°C, detector 300°C,
60

p~ig.

oven

helium pressure

Fatty acid methyl ester species were identified by comparison

with the retention times of appropriate fatty acid methyl ester standards.
The product of the retention times and peak heights for each sample

were used to calculate the relative percentage of each fatty acid in

the sample.
The phospholipids separated earlier were extracted from the
silic~

gel with 4 ml of

drop of water.
silica gel.

chlorofo~methanol

(1:1) ,and one

The tubes were vortexed and centrifuged to bring down the

The extract was poured into a clean tube and

procedure was repeated, pooling the two extracts.

the

The samples were
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dried, redissolved in 50

~l

of chloroform and each· sample was spotted

on the r.ight-hand corner of a Supelcosil 42A silicB: gel plate.

Two

dimensional thin-layer chromatography was performed in solvent
systems consisting of chloroform-methanol-water (65:35:4) for the
first dimension and, in chloroform-acetone-methanol-acetic acid-water
(5:2:1:1:0.5) for the second dimension.

Some plates were sprayed with

50% sulfuric acid and charred to visualize spots.

Other plates

were developed in iodine (Fisher) to visualize spots.

After the

iodine had faded, they were sprayed with ninhydrin: (0.2% in butanol,
Pierce) to detect phospholipids with amine groups.
circled and scraped into clean tubes.
the samples for phosphorous (95)

The spots were

An attempt was made to assay

us~g ~a2HP04·7H20

(Fisher) as a

standard.
Results

A normal fibroblast culture homogenate
activity at pH 4 than at pH·7 (Table 5).

showe~

greater lipase

The activity at both pH's

exhibited little inhibition at lO-5M E600 but significant inhibition
at IO-3M E600.'

However, at IO-3M E6o"O, the optical density at

the

first

point (2 min) dropped from 20 to 6, maki,ng the interpretation of the
results more difficult.

The lipase

activi~y

of the untreated Wolman's

disease culture homogenate, though less than normal, was, greater at

pH 4 than at pH 7 and also exhibited little inhibition at lO-5M E600
but signi,ficant inhibition at 10-3M E600

at

both pH's.

Pretreat~g

the enzyme source with E600 for 30 min did not appear to change
the inhibition greatly.

r-I
f".

TABLE 5
ACID LIPASE ACTIVITY OF NORMAL AND WOLMAN'S DISEASE CELL HOMOGENATES TREATED WITH VARYING CONCENTRATIONS OF E600.

Cell strain

pH

4

%

GM-37
(Normal)

7.

Activity
%

4

GM-1606
(Wolmants disease)

Activity
%

7

Activity
%

GM-37

c

(Normal)

4

0

10- 6

10-5

10- 4

10-3

2.21

2.12

l.94

1.59

0.01

100

96

88

72

0

0.97
100

1.00
103

0.. 83
86

0.66
68

0.08
8

0.64

0.81

0.04

127

0.63
98

0.27

100

42

6

0.36
100

0.48
133

0.56
156

0.35
97

0.06
17

1.44
100

1.91
133

1.24
86

0.80
56

0,0
0

E600 concentration (M):

Activity

Activity
%

b

8

aC~nfluentce11 cultures were trypsinized, pelleted, and sonicated on ice with a microtip sonicator,

Homogenates were assayed
for acid lipase by a f1uorometric technique with the appropriate concentration of E600 1n the assay mixture.

bNanomoles of 4-methylumbelliferyl oleate hydrolyzed perl min per mg protein.
cCells were exposed to the specified concentration of E600 for 30 min at 24°C prior to the assay.
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Whole normal cells treated witn E600 exhibited-reduced acid
activity (Table 6).

The reduction in acid lipase activity paralleled

increases in the concentration of E60D except at the highest

-3

10 M.

lipase

concentration~

-4M E600 exhibited levels of acid

Normal cells treated with 3 x 10

lipase activity comparable to those seen in Wolman's disease cells.
cells that had been treated with 10

When

-3
M E600 for 24 hr were removed from

E600 and grown in normal medium, there was no indication of the return
of acld lipase activity.
Separation of the major lipid classes by thin layer chromatography
(~ig.

34) revealed a large increase in cholesteryl ester in both Wolman's

disease and E60o-treated cells.

An increase in

t~iglyceride

was also seen.

The FCS lipid included much cholesteryl ester, but little triglyceride •
.The proportion of total lipid that was free fatty acid decreased in
E60o-treated cells.

However, because the total lipid per mg protein

of the E600-treated cells was much more than that of normal cells

(Table 7), the free fatty acid content of'E600-treated normal cells
actually showed a significant increase (p<.02) when the chromat.ograpp,ically
separated lipids were quantitated by dichromate assay and expressed per rug
protein (Table 8).

The E600-treated normal cells also showed significant

increases (p<.Ol) in cholesteryl ester, triglyceride, free
phospholipid.

choleste~ol,

and

The untreated Wolman's disease cells showed increased

cholesteryl ester and a slight in.crease in free tatty acid.

The GM-l606

culture, but not the GM-2211 culture, showed increased triglyceride.

The

E60D-treated Wolman's disease cells showed increases comparable to the
E600-treated normal cells, except that no further increase in free fatty
acid was observed.

GM-3557 (M),

G~3558

(F), the parents of the local

C"")
,....,

TABLE 6

ACID LIPASE ACTIVITY OF HOMOGENATES OF E600-TREATED NORMAL CELLS. a

Exposure time

24 hr.

11 days

10- 6

10-5

E600 concentration (M):

0

Activity c

0.71
100

·0.33
46

0.13
18

4.06
100

4.21
104

0.80

%

Activity
%

10- 4

20

3 x 10-4

10- 3

10- 3b

0.07
10

0.07
10

0.15
21

0.05
7

0.51
13

0.19

1.00
25

0.72
18

5

a Ce!l cultures were exposed to the appropriate concentration of E600 for the specified period'and then trypsinized, pe1leted
and sonicated on ice with a microtip sonicator. Homogenates were assayed for acid lipase by a fluorometric technique.
b Cells were treated for 24 hr and 10 days respectively with 10-3M E600.
medium for 24 hr.

They were rinsed with PBS and incubated in control

cNanomolea of 4-methylumbelliferyl oleate hydrolyzed per min per mg protein.

-..j"
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TABLE 7

LIPID AND PROTEIN CONCENTRATIONS OF VARIOUS FIBROBLAST CELL CULTURES. a

Cell strain

E600
treatment

Cell #
(xl06)

Protein! Cell
(pg)

Total lipid + S.D.
(~g) -

Lipid/Cell
(pg)

Hg Lipiq
. mg Protein

E600-treated cultures:
GM-179 (Normal)
Q"~-37

+

(Normal)

+

GM-l606 (Wolman's disease)

+

5.9
2.3
6.8
5.8
28.4
5.2

659
655
822
506
205
203

720 + 98
1167 ::;: 316
1081 +" 63
1813
83
2/~22 +" 309
1168 +" 134

121
519
159
311
85
223

193
615
416
1096

91
343
77
76
60
85
158
81
61

250
273
268
230
243
153
222
205
213

+

184
792

Untreated cultures:
GM-498 (Normal)
GM.. 2211 (Wo1,man' s disease carrier)

GM-2I21 (Wolman's disease)
GM-3557 (Proband's mother)
G~3558 (Proband's father)
G~2520 (Bloom's syndrome)
JoAI (Hetachrornatic leukodystrophy) ~2075 (Chediak-Higashi syndrome)
Black mouse (Normal)
Beige mouse (Chediak-Higashi
syndrome)
c

Fetal calf serum

-

12.7
0.6
25.8
22.3
46.6
6.2
9.4
13.8
42.6

364
1255
289
333
248
555
709
285

1153 + 13
189 +" 94
1994 +" 545
1706
346
2812 + 507
524 +" 118
1/~81
161
1120
32
2583
630

37.6

277

2108 + 255

56

203

1336 + 166

(267 lJg/ml)

13

396

(21 mg/m1)

+
+

+
±

a Confluent cell cultures. some treated with 10-3M E600 for 9 days, were trypsin1zed. counted on a hemocytometer, pe11eted,
and sonicated on ice with a microtip sonicator. After assaying for protein, the lipid was extracted in cl&lorofo~methanol
(1:1) and assayed three times. The calculations were corrected for the lipid removed during tne lipid and protein assay
procedures.

LJ")
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TABLE 8

MAJOR LIPID CLASSES OF VARIOUS FIBROBLAST CELL CULTURES (~g lipid/mg protein).a
b
Cell strain

E600 treatment

Phospholipid

Free
Cholesterol

Free
fatty acid

Triglyceride

Cho1esteryl
ester

E600-treated cultures:

GM-179

~125

+

373
124
327

39
57
39
51

11
23
10
16

138
13
83

0
200
7
138

+

165
402

47
85

24
23

42
207

139
379

155

15

GM-3558 (F)

165

45

CM-Z520
JoAl
GM-207S

103
143
145
138
146

35

41

26
17
,19
12
4
19
10
8
9

27
8
22
19
16

17

170
143

37
34
45
38

5

1

1

+
GM-37
GM-1606

10

Untreated cultures:
GM-498
GM-2211
GM-2121
GM-3557 (M)

Black

mou.~e

Beige mouse
Fetal calf serum

110

d

45
29
33

~y include some sulfatide storage.

14~

11
6

2

9

10
7

5
6
27
0

2

5

15

7

lLipid classes were separated by thin layer chromatography and assayed by an acid dichromate
calculated from relative percentages utilizing data from Table 7.

bDiagnosis of cell strains shown in Table 7.

96

tec~~ique.

Values were
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proband, and GM-2121, a known Wolman's disease heterozygote, appeared to
have normal amounts of lipid.

When the concentrations of each lipid class

per cell were ca.lculated (Table 9) the results were similar, but the
differences were not as significant, probably due to the added variable of
cell size being introduced.

The amount of protein per ce11 did not appear

to change s.ignificantly with E600 treatment (Table 7). The metachromatic
leukodystrophy culture, JoAl, did not appear to be storing large amounts of
sulfat:!.de by phase contrast microscopy.

Sulfatide probably was not

separated from phospholipid by the thin layer chromatographic technique
employed, so that rulY sulfatide stored in the JoAl cells was included in
the value shown for the phospholipid class (Tables 8,9), which did not appear
to be

unusually high.
Both Wolman's disease and E600-treated cells showed fatty acid

patterns similar to that of fetal calf serum, unlike the untreated nonnal
cells (Table 10).

The normal cells showed more stearic acid (18:0) than

oleic acid (18:lw9) in all three lipid classes analyzed, whereas Wolman's
disease cells, E600-treated

cells~

and fetal calf serum all had more oleate

than stearate. This was particularly noticeable in the cholesteryl ester
fraction, where all but the normal cells showed more than three times as
much oleate as stearate. The cholesteryl esters of normal cells also
appeared to contain more short chain fatty acids.

E600-treated normal and

E60D-treated Wolman's disease cells appeared to contain more 16:lw7 than
the untreated cells.The phospholipid plates showed good separation.

There appeared to

be increased sphingomyelin and lysophosphati.dyl ethanolamine in the E600treated cells.

The results from the phospholipid ana1ysis were poor but

appeared to indicate some increases in sphingomyelin. phospbatidyl
ethanolamine and, perhaps, phosphatidyl choline in the E600-treated cells.

r--..
r--..

TABLE 9

MAJOR LIPID CLASSES OF VARIOUS FIBROBLAST CELL CULTURES (pg lipid/ce11).8
Cell strainb

E600 treatment

Phospholipid

Free
Cholesterol

Free
fatty acid

Triglyceride

Cholestexyl
ester

E600-treated cultures:
CM-179
GM-37

82

25

+

244

7

37

lS~'

102

+

165

32
26

8
8

42

10
17

5
5

9
42

28

+

82

56

13

138
49

42

, 9
10

6
120
4
4

GM-1606

34

,7
90
11

0

131
6
70

77

Untreated cultures:

GM-49B
GM-2211
GM-2I2l
GM-3557 (M)
GM-3558 (F)
GM-2520

JoAl

48
41
57

~l

5
33
5
6
3

19

2

14,

13
13

102

32

GM-2075

57

Black mouse
Beige mouse

39

12
10

40

11

Fetal calf serum

98 Vg/ml

23 lJg/ml

'+

2
2

13 Vg/ml

6

6
4
1
7
6
2
2

32 )Jg/ml

. a Lipid classes were separated by thin layer chromatography and assayed by an acid dichromate technique.
calculated from relative percentages utilizing data from Table 7.
b
c

Diagnosis of cell strains shown in Table l.

May include some sulfatida storage.

1
5
4
2
8

0
100 )JS/ml

Values were

00

"'"

TABLE 10

DISTRIBUtION OF FATTY ACIDS IN DIFFERENT LIPID CLASSES OF

NO&~,

WOLMAN'S DISEASE, AND E600-TREATED CELL CULTURES.

a

Distribution of fatty acids (%)
Upid clas8

Free fatty
acid

Triglyceride

Choleatery1
ester

Sample

<16;0

16:0 ,

16:1w9

16:1w7

18:0

18:1w9

18:1w7

29.7

22.5
21.4
16.8
21.7

27.2
32.7
34.5
34.7
28.6

7.0
11.8
11.1
11.6
9.8

26.7
13.5
22.9
11.7

23.2
38.4
34.6
37.0

15.2
17.7
15.2

GM-179
GM-179 +E600
GM-1606
GM-1606 + E600
Fetal calf serum

1.9
3.9
2.0
0.8
1.6

22.7
19.9
19.4
18.1
27.1

1.8

3.2
3.9
3.5
2.5

2.3
6.0
2.4
7.7
2:1

GM-179
GM-179 + E600
GM-1606
GM-1606 + E600
Fetal calf serum

6.4
1.9

30.6
21.6
24.8
22.8
50.0

5.9
3.8

5.6

3.8

8.6

32.7
22.7
26.6
27.2
32.6

4.9
2.8
2.4
2.7
2.6

GM-l79
GM-179 + E600
GM-1606
GM-1606 + E600
Fetal calf serum

1.1
9.6
7.2.
1.8
2.1
2.6

18 :2w6

other

4.2

3.3

1.9

3.4
6.8

6.6
10.6

40.5
7.6
4.0
5.9
7.6
5.3

23.5
9.7
7.1
7.2
7.2

19.3
32.9
35.1
31.1
23.0

9.S
8.6
9.6
9.4

13.3
5.7
5.7
9.4

4.7
5.2
7.2
6.7
7.9

a Confluent cell cultures were trypsinized, pe11eted, and sonicated on ice with a micro tip sonicator. Lipid was extracted
with chlorofo~methano1 (1:1) and the major lipid classes were separated by thin layer chromatography. Fatty acid methyl estexe
were prepared and purified by thin layer chromatography. The retention times and peak heights were recorded on a gas
chromatograph and used to calculate the relative percentages.

~igure 34~

Separation of major lipid.classes of various cell cultures

by thin layer chromatography. (A) Free choles terol control; (B) T~iglyceride

control; (C) Black mouse, normal; (D)

B~ige

mouse,

Chediak-~igashi

syndrome; (E) GM-2075, Chedlak-Higashi syndrome; (F) Fetal calf serum;
(G) GM-179, nonnal, treated with lO-3 M E600; (H) GM-37, normal, untreated;

.
- 3 ·
(I) GM-37, normal, treated with 10 M E600; (J) Cholesteryl. ester
control; (K) Free fatty acid control; (L) GM-498, normal; (M) GM-l606,
Wolman's disease, untreated; (N) GM-1606, Wolman's disease, treated with

lO-3M E600; (0) GM-3558, father of proband;' (P) GM-3557, mother of

proband; (Q) GM-2121, Wolman's disease heterozygote; (R) JoAl,
metachromatic leukodystrophy. E600 treatment lasted 9 days.
extracted from pelleted cells an.d separated on

silic~

Lipid was

gel plates.

The

plates were dried, sprayed with sulfuric acid, and.heated to visualize
the lipids.

From 350 to 500

.~g

of lipid were used for each culture, so

plates show .relat~ve·percentages of each lipid class.

T~iglyceride

.

.control did not char after sulfuric acid spray and heating because it
cOlltained only saturated fatty acids.
;FA-fatty acid,

TG-t~iglyceride;

PL-phospholipid; C-cholesterol;

CE-cholesteryl ester.
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Discussion

Fibroblasts differ from liver cells in having more lipase
activity at acid pH than at neutral pH (9,14,96).

The observed

lipase activity was resistant to lO-SM E600, indicating that
it probably represented aci.d lipase at both pH's (16,17).

Acid

lipase usually shows a more narrow pH range for activity (9,14).

The wide range seen may be due to the buffer system or substrate,

or it may reflect the relatively low activity of the material
examined and the consequent decreased accuracy of the assay.
The conclusion that even the lipase activity at pH 7 was due
to acid lipase is supported by the

find~ngs

of other investigators

that nearly all the lipase activity of fibroblasts is due to

acid lipase (9,14).
E600-induced inhibition of acid lipase was generally consistent
with the histochemical dose and time dependence studies in Research

Section II (Figs. 20-22). Although 10-6M E600 had no detectable
effect on lipid storage or acid lipase activity, at lO-5M E600
there was an 80% inhibition of acid lipase \vith little to no
effect on lipid storage.

Brovm et al. (10) showed that as little

as 10% of normal acid lipase activity may be sufficient for normal
function in fibroblast cultures.

An 88% inhibition of acid lipase

and definite lipid accumulation were seen in cells treated with

lO-4 M E600.

Treating cells with 3 x lO-4 M E60D caused a 95%

inhibition of acid lipase with slightly more lipid accumulation

than at 10-4 M.

Although 10-3-M E600 induced a more progressive

time-dependent accumulation of lipid, acid lipase activity did

81
not appear to be maximally inhibited at IO-3M E600.

In two assays,

acid lipase activity decreased as a function of E600 concentration
-4
-3-4
until 3 x 10 M, but showed less inhibition at 10 M than 3 x 10 M.

Cell cultures treated with 10 -3M E600 for 3 hr, 1 day, and 9 days
each

e~libited

activity_

approximately 75-80% inhibition of acid lipase

It is not clear why this occurs.

Although E600 did not

totally inhibit acid lipase, assays for acid lipase in which
esters of 4-methylumbelliferone are utilized, generally show appreciable
residual activity even in acid lipase deficient cultures (7).
The analysis of lipid in Wolman's disease and E600-treated cells
supported the histochemical

find~ngs

cholesteryl esters in the cells.

in showing increased stor,age of

The results also showed increased

tt::ig1yceri.de, which cannot be specifically ,demonstrated histochemically.
S~ight

increases in free fatty acid and cholesterol in E600-treated cells

were observed both histochemically and by lipid analysis.

The latter

findi,ng was unexpected, because the deficiency or inhibition of an
enzyme in a metabolic pathway usually leads to a decreased level of the
products of the inhibited reaction.

Degradation of the stored lipid by

normal or artifactual processes may account for this finding.

Free fatty

acid has been reported to be increased in histological (89,97) and
biochemical (46,97) studies of tissues from Wolman's disease patients.
Increased free fatty acid was also· seen in biochemical analysis of the
liver of the donor of Wolman's disease culture GM-2109 (P)
~

(Dr. H. Jons.son, personal communication).

The increase in

phospholipid found in E600-treated cells was not observed histochemically,

82' "

altho.ugh there was increased phosllhollpid .staini,ng in a
regi,on of the cells which;t it was
~egion.

th~ugh.t, ~ght

.peX'inucl~ar

represent. the

G~lgi

Numerous amphiphilic compounds have.been shown to induce

phospholipidos is (98-100).

However J E600 lacks the posit! vely ch.arged,

nitrogen
containing,
hydrophilic side chain common to these compounds.
.
.
The analysis of the phospholipid classes gave no definite result, but it
appeared that sphingomyelin, phosphatidyl ethanolamine, lysophosphatidyl
ethanolamine and phosphatidyl choline might all be elevated.

No

significant increase in any lipid class was seen in known or suspected
Wolman's disease heterozygotes.
shown in Fig. 12.

This supports the histochemical findings

Although cells from one carrier were reported to

store lipid (42), most carriers probably do not.
The observed lipid accumulation in cells treated with E600
appears to result, at least in part, from the specific inhibition
of acid lipase, explaining the similarities of E600-treated cells
to Wolman's disease cells.

Although acid lipase is fairly

resistant to E60D (13,16,17,101), fibroblasts appear to have little
other lipase activity (9,14) so that no cellular effeet may be
manifested until acid lipase is inhibited.

However~ ~he

storage

of additional triglycerides and cho1esteryl esters ·tm Wolman's
disease cells treated with lO-4M E600 indicates

eit~ the

inhibition of residual acid lipase activity or the

~ibition

additional enzymes involved in lipid metabolism.

Oa1rtner e tal.

(8)

were able to separate,

by

cel~ogel

electrophonesis,

of
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three isozymes with the ability to cleave 4-MUO under acid
conditions, only one of which was deficient in Wolman's disease.
It is possible that E60D is also blocking the other isozymes

which may have different substrate specificities (8).

The

increased levels of phospholipids in E600-treated cells suggest
that one or more enzymes jnvolved in phospholipid degradation

may be inhibited by E600 treatment as well.
The gas chromatography results support the conclusion

that the cholesteryl ester stored in Wolman's disease and E600treated cells is derived from the cholesteryl ester component
of low density lipoprotein in the serum and has not been metabolized

in the cell.

However, normal cells degrade the lipid and,

When the cholesterol is transported from the lysosome to the

cytosol, it is re-esterified.

The normal cells showed

a differenx

pattern of fatty acids in the cholesteryl ester fraction, suggesting
that more stearic acid (18:0) is available for re-esterifation

than oleic acid (18:1009) or that the cholesteryl ester synthetase
preferentially esterifies the saturated fatty acid.
was little triglyceride present in fetal ca1f serum.

There

The triglyceride

present in the cells was probably derived from the serum free
fatty acid (66,67).

The E600-treated cells may have preferred

oleic acid (18:1009) to stearic acid (18:0) in the synthesis
of triglyceride.

The gas chromatography of cultured Wolman's

disease fibroblasts gave results similar to those of other
analyzed Wolman's disease tissues (46,77,78,91) except for
an increase in -stearic acid in the triglyceride fraction.

RESEARCH SECTION IV
The ultrastructural appearance of the
of lysosomal

sto~age

sto~age

diseases is characteristic of the disease

and in some cases can be used for d1.agnosis (102).
fibroblast cultures do show
disease (102,103)

J

products

morpho~ogy

Ornoy' et a1.

Although

typical for a specific

(103) have s,uggested that amniotic

fluid cells are more reliable for diagnostic purposes.

In Wolman's

disease, the ultrastructure of liver (16,69,104), adrenal (69),

lymph node (46), duodenum (104), lymphocytes (101), and for the
peripheral and central nervous system (70) have been reported.
Numerous lipid droplets and clefts are structures typically
observed.

Some

inves~igators

have reported that lipid can be

either membrane-limited or free in the cytoplasm (69,70) whereas

others have reported that the lipid is membrane-bound (3,16,101).
The lipid has been observed in lysosomes, associated with acid
phosphatase activity (3,16,69).

In cholesteryl ester storage

disease, Partin and Schubert not only demonstrated lipid droplets
and cholesteryl ester clefts in a detailed study ofsma11
intestinal biopsies (79), but they also demonstrate4 the presence
of membrane-bound crystals in fibroblasts cultured from the
patient (105).

Dr.ug-induced lipidoses resemble, ultrastructurally,

inherited lipid stor,l:lge diseases (98,100) particularly those
involving a similar

sto~age

product.

This section presents ultrastructural and cytochemical
studies on Wolman's disease and E60o-treated fibroblasts and
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attempts to c.orrelate the information with the histochemical and
biochemical data.
Materials and Methods
Normal (GM-179) and Wolman's disease (GM-1606) cells were seeded in
35 x 10 mm culture dishes at a concentration of 5 x 10
dish.

4

cells per

Half the normal cells were treated 11 days with 10 -4M

E600 (diethyl p-nitrophenyl phosphate) and embedded in situ by the
method of Douglas et al. (106).

The cells were rinsed 3 times in Puck's

balanced salt solution (PBS) (0.9% NaCI for acid phosphatase cells) and
fixed 30 min in

2.5~

glutaraldehyde (EMS, Fort Washington, Pa.) in 0.1 M

sodium cacodylate (Fisher) buffer.

The cells were rinsed in 0.2 M

cacodylate buffer and post-fixed 30 min in 1% osmium tetroxide
(EMS) in 0.1 M cacodylate buffer.

After dehydration in graded alcohols,

the cells were infiltrated in Epon-ethanol (1:1) and then 4 changes
of Epon (EMS).

The next morning, after 2 additional changes of

Epon, the culture dishes were polymerized at 55°C for 12 hr.

The

polymerized cells were removed from the culture dish with pliers
and cured for 30 hr at 60°C.

The dishes were staineiwith toluidine

blue and suitable areas were marked.

These sections were cut out

with a coping saw and placed in a Beem Capsule in whi£h they were
flat-embedded with Epon.
(E~68)

Thin sections were examinei on an AEI

or Hitachi (HS-8F-l) electron microscope.

The· GM-1606

monolayers partially detached during glutaralydehydefixation,
so less cells were available for examination.

~rEholor~:

After thin sections were cut and placed

o~

grids,

the sections were stained in saturated uranyl acetate (Fisher)
in 50% ethanol, rinsed in distilled water and stained in lead

citrate (from lead nitrate, Fisher, and sodium citrate, EMS).
Colloidal Gold:

Approximately 55 ml of

waS boiled down to 6 ml with stirring.

colloida~

gold (Harleco)

This was di1ute.d in

medium (1:2) and used to treat the cells for either 2 or 24

hr before fixation.
Acid Phosphatase:

After glutaraldehyde fixation, staining

solution was prepared by dissolving
63 .mg of a-glycerophosphate
.
(Sigma) in 5 ml of 0.2 M Tris maleate buffer, pH 5.0
and 10 ml of distilled water.
with. hydrochloric acid.

(Sigma)

The pH was readjusted to 5.0

To this solution was added 10 ml of

0.2% lead nitrate, drop by drop with stirring.

Control solution

was prepared similarly, but lacked B-glycerophosphate.

The

cells were treated for 1 hr at 37°C.
Peroxidase:

After glutaraldehyde fixation, staining

sol~tion

was prepared by dissolving 3 mg of 3,3'-diaminobenzidine tetrahydrochloride (DAB, Sigma) in 10 ml of 0.05 M

Tris buffer pH 7.2-

7.6 (Fisher) and approximately 0.02 m1 of 3% hydrogen peroxide
(Parke-navis).

Control solution was prepared without DAB.

The cells were treated for I hr at room temperature.
Scanning Electron

~croscopy:

Normal cells (GM-37) and Wolman's

disease cells (GM-1606) were seeded on coversl1ps in culture
dishes as described in Research Section I.
was treated 8 days witn

10·~ E600.

One dish of each

The cells were fixed
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30 min in 2.5%. glutaraldehyde in 0.2 M cacodylate buffer,
rinsed in buffer t post-fixed one hr in 1% osmium tetroxide
in 0.1 M cacodylate buffer, and dehydrated in graded alcohols.
Critical point
point

dry~ng

dry~ng

was performed in a Technics CPA-II critical

apparatus and, after attaching pieces of coverslip

with cells to specimen mounts with silver paint (Dotite
Electroconductives), the samples were coated

wit~

min on a Hummer II vacuum evaporator (Technics).

gold for 2.5
Cells were

examined on a Jeol JSM-25 scanning electron microscope and
Polaroid pictures were taken.·
Results
Transmission electron microscopy (TEM):

Normal fibroblast cells

fixed in situ and examined by TEM revealed features typical of
an active cell (F.igs. 35,36).

Abundant rough endoplasmic

reticulum and long thin mitochondria were present.

Round dense

bodies probably representing lysosomes were seen scattered throughout
the cytoplasm and osmiophilic cytoplasmic lipid droplets were
occasionally encountered.

Large clear vacuoles were also observed. Thin

filaments which were probably microtubules and microfilaments, were

numerous.

The nucleus usually appeared rounded and two or more nucleoli

were visible.

The ce.l1s appeared to have minimal acid phosphatase

or peroxidase activity.
the cells, although some

After 2 hr little colloidal gold had entered
was visible at the cell surface.

After 24 hr

however, more( colloidal. gold had entered the cells and could. generally
be seen in dense bodies, large clear vacuoles,

or occasionally
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in small endocytic vacuoles of intermediate density (Figs. 37,38).
Wolman's disease fibroblasts showed morphology similar to
normal cells though some dilation of rough endoplasmic reticulum was
observed.

Crystalloid clefts probably representing cholesteryl ester.

were visible within dense bodies that were often deformed by the shape
(~igs.

of the crystals
appeared more

39-41).

~ngular

Large clear vacuoles were numerous and

than in normal cells.

Again no significant reaction

was seen for acid phosphatase or peroxidase and little colloidal gold
had entered the cell after 2 hr.
to have had some

After 24 hr the colloidal gold appeared

effects upon the cells.

~egative

swollen and had areas of clearing.

The mitochondria were

Colloidal gold was usually seen in

dense bodies, some of which contained lipid clefts, or in the large
clear va cuoles

(~igs.

42,43).'

. Normal cells treated with lO-4 M E600 exhibited numerous lipid
clefts.

Thev generally appeared to be present in dense bodies which,
til,

as in the Wolman's disease cells, often were deformed by the shape of
the crystalloid material (Figs. 44-46).
of dense bodies (Fig. 44).

The cells showed increased numbers

Large clear vacuoles were numerous.

An

increase was also observed in multilamellar structures (Fig. 45), similar
to the lamellar bodies typically seen in

(98).

Cells treated with

colloida~

drug-in~uced

phospholipidosis

gold for 24 hr exhibited colloidal

gold particles in endocytic vesicles and dense bodies, some of which
contained lipid clefts (Figs. 47,48).
also seen in the

l~rge

clear vacuoles.

Colloidal gold particles were
Aside from an increase in

the number of dense bodies, the E600-treated cells resembled

Wolman's disease cells.

Osmiophilic cytoplasmic lipid drop Ie ts

F,igure 35,
in situ.

are

l~ng

Ultrastructure of a GM-179, normal fibroblast fixed

Abundant-r~ugh

and thia.

endoplasmic reticulum is visible.

Mitochondria

The few dense bodies are c.lustered near ,the nucleus

or,scattered,thr~ughout

the cytoplasm.

N~nucletls;Nu-nucleolus;

DB-dense body; ER-rough endoplasmic reticulum; M-mitochondrion.
Stained wi.th uranyl acetate and lead citrate.

X5500.
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,"

~1gure

power.

36.

A GM-179,normal fibroblast viewed at a

~igher

Microtubules and.numerous microfilaments are present in the

cytoplasm. Dense bodies and less d.euse vacuoles are also present.
N-nucleus; DB-dense body;

ER-r~ugh

endoplasmic.reticulum;

Mrmitochondri.on; Xfb-microfilament bundle.
acetate and lead citrate.

X15,800.

Stained with uranyl

90 .

~igure

37.

Colloida~

GMr179 , normal fibroblast.

,gold particles within dense bodies of a
One colloidal gold particle appears

to be within a small endocytic vesicle (arrow).
lipid droplet.

L-probable cytoplasmic

Treated with colloidal gold for 24 hr.

Xl7,OOO.
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gold particles in a GM.... l79, normal
e in dense bodies and large clear vacuoles
cytoplasmic lipid

hr.

Xl6,800.

oplet.

Treated with
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.~igure

fixed in situ.

39.

Ultrastructure of a GM-1606, Wolman's disease fibroblast

The cytoplasm contains many

l~ng

crystalloid clefts which

probably represent cholesteryl ester dissolved during processing.
Thoe crystalloid was often present in dense structures resembling lysosomes.

Few normal dense bodies are seen.

Large.clear vacuoles are present,

.but appear more B:ngular than in normal cells (arrow.s). N-nucleus, ER-rough
endoplasmic reticulum; M-mitochondrion.

lead citrate.

X5600.

Stained with uranyl acetate and
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~igure

a

~igher

40.

power.

A GM-l606, Wolman's

d~sease

fibroblast viewed at

Numerous clefts are visible within dense bodies,which

are often deformed by the crystalloid (small arrows).
visible
arrows).

surround~ng

The

Nu-nucleolus;

r~ugh

Membrane is

some crysta.lloid-containing structures' (la.rge

endoplasmic reticulum is dilated.

ER-r~ugh

endoplasmic reticulum.

acetate and lead citrate.

Xl5,500.

N-nucleus;

Stained with uranyl
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~igure

fibroblast.

41.

Unusual structures in a GM-l606, Wolman's disease

In addition to the more typical

crystalloid-contain~ng

dense bodies (small arrow), some cells.contained
bodies.

Some of the multivesicular

crystalloid
citrate.

(l~rge

X32,300.

arrows).

bod~es

l~rge

multivesicular

also appeared to contain

Stained with uranyl acetate and lead
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~igure

42.

disease fibroblasts

Colloida~.gold
.show~ng

particles in GM-1606, Wolman's

local;Lzation to ,dense bodies and la,rge

clear vacuoles (large arrows).

Some

crystalloid-contain~ng

also accumulate colloidal: gold particles (small arrows).

lipid droplets did not appear to.be associated with

particles.
X32,OOO.

structures

Cytoplasmic

colloida~

Treated with.colloidal.gold for 24 hr. X15,OOO.

gold
Inset
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F,igure 43.
colloida~

A GM-1606, Wolman t_s disease fibroblast exhibiti.ns

gold accumulation within dense.bodies and

vacuoles (arrows) .which appear
material.
.but

a~e

Col1oida~

~ngular

l~rgeclear

and may contain crystalloid

gold particles are.also-seen

atthe.cellsu~face,

not associated with cytoplasmic lipid droplets •. Treated

.~th colloida~

gold

£o~

24 hr.X14,700.
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~igure

44.

Ultrastructure of a GM-179,.normal fibroblast

treated with lO-4 M E600 for 11' days and fixed in situ •. The cytoplasm

is nearly filled with 18:rge clear vacuoles·ap.d.dense bodies which
.often contain semilunar or angular electron.lucent areas.that

probably represent cholesteryl ester

disso1ved.dur~ng process~ng.

A

small.perinuclear zone lacking dense bodies is visible (arrow) which
. contains mitochondria,
.bundles.

r~ugh

endoplasmic reticulum, and microfilament

N-nucleus; M-mitochondrion •. Stained with uranyl acetate

and lead citrate.

X5400.
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f

f

..

I

I

~igure

45.

a higher power.

An E60Q-treated, normal (GM-179) fibroblast viewed at

Numerous dense bodies contain

clefts, some of which. deform

t~e

~ngular

and.semilunar

shape of the dense bodies (small arrows).

Some bodies appear to contain concentrically arra.ngedmembranous
materials

(lB:rge arrows).

N-·nucleus; ER-rotigh endoplasmic reticulum;

M-mitochondrion; V-l8:rge clear vacuole; Mfb-microfilament bundle •
.Stained with uranyl acetate and lead citrate. -X16 ,500.
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·

~igure

46.

fill~ng

lipid droplets
fibroblast.
bodies.

A.

Dense bodies, clear vacuoles, and cytoplasmic
the cytoplasm of an-E600-treated, QI-179, normal

Angular and semilunar-clefts are visible within dense

L-probable cytoplasmic lipid droplet.

body appears

-to-befus~ng

a dense matrix.

X15,500.

X17,500.

B.

Dense

with a lipid cleft which is already within
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Figure 47.
clear ,vacuoles
blast.

Some

Colloida~

(l~rge

arrows)

gold particles in dense bodies and la,rge

of an E60Q-treated, GM-179, normal fibro-

crystal1oid-contain~ng

particles (small arrows)

41

structures accumulate

colloida~

gold

Treated with colloidal gold. for 24 hr .X16 ,600.
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~igure

48.

Accumulation of

bodies of an E60D-treated,
some.times associated wi.th

G~I-179,

colloida~

gold particles in.dense

normal fj.broblast.

crystal1oid~contain~ng

Colloida~

structures.

gold is

One

.colloidal gold particle is associated'witn a cytoplasmic lipid droplet
.(l~rge

arrow), but this droplet may.be

next to.it which.contains
for ·24 hr.· .X15,500.

colloid~

fus~ng

with a secondary lysosome

gold •. Treated

withcolloida~

gold
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•

~igure

Normal, GM-37. (A,e) and Wolman 1 s disease, GM;-1606 .
. · - 4
.(B,D) fibroblasts, untreated (A,B) and treated with 10 M E60Q ... (C,D)

yiewed

49.

by.scann~ng

electron microscop¥.Cells show.nuclei, nucleoli,

and ndcrofilaments .runn~ng

E600-treated cells

l~ngthwise

.show.bumps.thr~ughout

.perinuclear clear zone (arrows).
.al~ng

thro.ugh the cells. . The

microfilaments.

X1400,45°

the cytoplasm except for a

Tile humps appear to form
~gle.

r~dges

10 3

~igure

50.

Possiblemechanisms.to explain.the presence of

crystalloid material within. secondary lys.osomes.
with a lipid cleft

ly~ng

free in the cytoplasm.

A .lysosome fuses

A.

The.lysosome engulfs

the.c!eft,whichthereby.alters.its shape • . Eventually another
lysosome may .fuse with this structure.
within the lysosome .which is unable to
taken up, the cleft.expands,

B.

A lipid cleft

~egrade

stretc~ng.the

.it.

~egins

.forming

As more lipid is

lysosome.

As in A,

eventually another lysosome may.fuse with this structure.
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/
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did not appear to be increased in
E60o-treated cells and

e~tne~.Wolman'a

did.no~,generally

particles • . The amount of

colloida~

contain

disease or
colloida~.gold

gold uptake varied from cell

to cell but was not appreciably different in either quantity or
location in the normal~ E60o-treated, or Wo1man's disease cells.
Scanning electron microscopy (SEM):

Normal cells were indistinguish-

able from Wolman's disease cells by SEM (Fig. 49 A,B).

The nucLei

appeared as smooth ovoid areas with 2 to 4 raised nucleoli.
strands could be observed running parallel to the

of the cell.

Thin
axis

l~ngitudinal

Aside from these filaments, the cytoplasm appeared

Pits were present in the cytoplasm and may have reflected

smooth.

the presence of vacuoles covered by fragile areas of cytoplasm,or they
may have represented artifacts of critical point drying.
Nonnal cells and Wolman's disease cells treated with 10
E600 showed a distinct change in

morpho~ogy

(Fig. 49 C,D).

-4
M

The

cytoplasm became bumpy and the bumps sometimes appeared to be
linear, running alc,ng the filaments.
observed which showed no bumps.

A perinuclear zone was

This was comparable to a clear

perinuclear area seen by neutral red (Fig. 32) and oil red 0
stain~ng.

The b.umps thus appeared to represent the lysosomal

lipid storage granules.
Discussion

Altho,ugh lipid clefts have been noted in both

~ight

and

electron microscopic studies of Wolman's disease, only Lake and
Patrick (16) reported that the crystals were membrane-limited, but
they showed no illustrations.

Partin and Schubert (105) reported
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that fibroblasts from a patient with cholesteryl ester stor,age disease
contained "semilunar or B:ngular,electron,lucent

i~ges

innnersed in an

electron dense material contained Ul membrane bounded structures '
probably lysosomes."

This is similar to what we observed in Wolman's

disease and E600-treated cells.

The.deformation of . the structures by

crystalloid material has not been previously noted.

The presence of

the clefts and the concomitant alteration in morphology did not
appear to interfere with the activity of the structures in fusing
with endocytic vesicles containing colloidal gold.
Acid hydrolases are manufactured in the cellon the ribosomes

of the rough endoplasmic reticulum and are transported via the endoplasmic
reticulum to the Golgi.

In the Golgi the hydrolases are

packag~d

and,

when they bud off the Golgi membrane, they are known as primary
After pinocytotic vesicles and

lysosomes.

p~agocytic

vacuoles are

formed at the cell surface, they are transported through the cytoplasm
and fuse· with a primary lysosome which thereafter is called a

secondary lysosome (phagolysosome).

The secondary lysosome digests

the endocytosed material and continues to fuse with new endocytic
vesicles.

Eventually the lysosome accumulates indigestible material

and becomes less active.

It is now called a residual body.

gold particles are la.rge and

Colloidal

inert and they cannot pass through

the pIa.sma membrane, .but they are taken up by endocytosis.

When the

colloidal gold-carrying endocytic vesicle fuses with a 1ysosome,

the colloidal gold remains in the secondary lysosome for it cannot
be digested.

Thus secondary lysosomes accumulate colloidal gold (107).

The crystalloid-containing dense bodies, which were generally larger and
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denser thanendocytic vacuoles, contained
considered to be secondary lysosomes.

col1oida~

gold and were thus

Because Wolman's disease and

E60o-treated cells stored vastly more cholesteryl ester than normal
cells (Research Section III), it is likely that the crystalloid clefts
consisted mainly of chdlesteryl ester.

Two mechanisms can 'be hypothesized to result in the presence of
crystalloid within secondary lysosomes.

If cholesteryl ester clefts

were found free in the cytoplasm, perhaps in a struc,ture like the
clear vacuole, one or more lysosomes might fuse with the crystalloid
and engulf it (Fig. 50A).

Such a mechanism is

s~ggested

by Fig. 46.

The accepted mechanism of cholesteryl ester uptake'ri.a the 1m., density

lipoprotein pathway

lysosomes due to the

s~ggests

that the clefts may

,~ggregation

of

sto~age

fo~,

in the

material (Fig. 50B).

The 18:rge clear vacuoles were seen in all cell t:ypes, but appeared
to be more numerous and to be more angular in
E600-treated cells.

Wolmam~s

The angularity may have been

of cholesteryl ester crystals.

sto~age

to the presence

The vacuoles may repttesent non-osmiophilic

lipid droplets, which Partin and Schubert noted in
cholesteryl ester

~,

disease and

<~rophages

in

disease (79) or macropinocJttotic vesicles (108).

The vacuoles were often seen in association with lysmomes and sometimes
the lysosomal membrane appeared to extend around the

~cuole

lysosome were attempting to engulf
the clear vacuole.
.
,

as if the

The presence of

colloidal gold in some of the clear vacuoles t. generaIn:y at the periphery
of the vacuole, suggests that some of these vacuoles
lysosomes.

~d

fuse with

Alternately, the clear vacuole may form wnthin a lysosome

and cause expansion.

Other lysosomes may then fuse with it.

These
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hypotheses are analogous to those discussed for

cholesteryl ester

crystals and depicted in Fig. 50.
No morphological evidence of damage was noted in cells treated with
E600.

The dilation of rough endoplasmic reticulum seen in Wolman's

disease cells may

have~een

due to the glutaraldehyde fixation procedure.

The damage appeared to be slightly more severe in the Wolman's disease
cells incubated in colloidal gold for 24 hr.
Increased numbers of dense

bodie~many

clefts, were obvious in E60D-treated cells.

containing crystalloid
This supports the conclusion

shown in Research Section II that E600-treated cells, because they show

.

increased numbers of neutral red granules, have an increased number of
lysosomes.

Although direct stimulation cannot be ruled out, it seems

likely that this is caused indirectly and represents an attempt by the
cells to clear the lipid accumulations induced by E600 treatment.

The longitudinal filaments observed by SEM have the same morphology
as actin stress fibers in human (109) and mouse (110) fibroblasts.
Acti.n filaments are

th~ught

to be involved in the spreading of

fibroblasts (Ill) and the maintenance of cell shape as well as such
diverse and important processes as growth, adhesion to the substratum,

and cellular motility (109).

The apparent a1lignment of the E600-induced

lysosomes along actin filaments supports the observation of linear neutral
red granules that were particularly noticeable in the GM-2121 culture
(Fig. 32).

Although fixation and drying might cause organelles to

line up against resisting structures like bundles of actin filaments,
the apparent association of lysosomes and actin filaments in the

unfixed neutral red stained cells makes it likely that this is not an
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artifact of fixation.
Ph:ago1ysosomes

Actin has been shown in fibroblasts surrounding

cOI1tain~ng

latex beads. (112).

An association between

lysosomes and microfj.laments has been reported in polymorphonuclear
leukocytes (113), by both TEM and SEM.
that the contractile

pro~ein

\

It is

tempt~ng

to speculate

actin may direct or at least modulate the

intracellular movements of lysosomes.
The clear perinuclear area visible by SEM and neutral red
staini,ng of E600-treated cells was stained by the copper phthalocyanin

procedure for phospholipids (Research Section'II).
G~lgi

was observed in this area.

By TEM, little

Lipid-containing lysosomes, which

filled most of the cytoplasm, may have displaced other cell organelles
to this area.

This area did seem to show a

s~ight

increase in the
.....

concentration of
TE~1 (:b~ig.

44).

r~ugh

endoplasmic reticulum and mitochondria by

Perhaps the concentration of membrane in this area

increased sufficiently to be visualized by the phospholipid staini.ng
procedure.

DISCUSSION
Fibroblasts derived from a child with Wolman's disease exhibited

a long #5 chromosome, but this

find~ng

was called into question when

cells that had been stored frozen did not show the anomaly.

If the

initial finding was rep\esentative of the karyotype of the proband, a
translocation probably occurred in the father's germ cells or in an early
mitotic division of the zygote, resulti,ng in the deletion of the
father's normal acid

lipas~

gene and suggesting that the acid lipase

gene locus may be on chromosome #5.

If the initial karyotypic

find~ng

was an artifact of tissue culture, either individual variation in
the father's acid lipase level and variation within the assay resulted
in his not appearing to be a carrier, or the presumed father was

not the true father of the child and the true father was a carrier

for acid lipase deficiency.

The different Wolman's disease cell

cultures stored different amounts of lipid which may have depended

on the rate of proliferation of the cell cultures.
Normal cells treated with the esterase inhibitor E600 exhibited
time dependent lipid storage that appeared maximal at lO~3M E600.
The stored lipid appeared to be derived from serum lipid.

As in

Wolman's disease, triglycerides and cholesteryl esters accumulated.
In addition, howe.ver, phospholipid storage

and slightly increased

free cholesterol and free fattY,acid storage were observed.

Wolman's

disease cells, which are deficient in acid lipase, after treatment with

E60Q,showed comparable increases in all lipid classes but free fatty
acid,

imply~ng

that E600 inhibited some enzyme activity present in

Wolman's disease cells.

The phospholipid storage suggested inhibition
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of an additional en.zyme.

E600-treated cells exhibited.reduced acid

lipase activity, showing that acid lipase deficiency was probably
partially responsible for the lipid storage.
Ultrastructurally, Wolman's disease and E600-treated normal
cells showed lipid clefts within dense bodies that were sometimes
associated with colloidal gold particles.

The E600-treated cells

exhibited increased numbers of dense bodies and had increased neutral
red granules by

~ight

When viewed by

microscopy.
scann~ng

electron microscope, Wolman's disease

cells. resembled normal cells, but E600-treated cells showed bumps
that appeared to represent structures arranged lineraly alo.ng actin
filaments.

A similar arrangement was s.ugge~ted by neutral red~Astainlng.

Altho.ugh E600 was found to induce lipid

sto~age

in all tes ts,

in the early experiments presented in much of Research Section II,
the optimum concentration appeared to be 10
experiments, such as the. gas

-3
M E600, whereas in later

chroma~ography

and electron microscopy,

the optimum concentration appeared to be lO-4M E60D.

In the later

-3
experiments 10 M E600 was more toxic to the cells.

There are two

likely

eh~lanations

for this

find~ng.

E600-treatcd cells showed

less toxicj.ty when grown on glass than when grown on polystyrene.

In all the histochemical experiments the cells were grown
coverslips.

o~

glass

For the' lipid biochemistry and electron w~croscopy

however, the cells were grown in polystyrene flasks or culture dishes
respectively.

It is worthy of note that the relative toxicity and

growth curve experiments, early experiments in which the cells were
grown in polystyrene culture dishes, showed significant toxicity
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at lO-3M E600.

Perhaps the E600 binds to the plastic, presenting

an increased local concentration where the cells are present.

However,

there still appeared to be an increased effect of 10-4M E600 on
cells

gro~~

on. glass coverslips in late experiments.

Different

lots of FCS were utilised in the early and late experiments.

It

is possible that the different lots varied in paraoxonase activity.
If the FCS used in the later experiments had less paraoxonase activity,
the treated cells would eA-perience an effective increase in the
concentration of E600.

The increase in phospholipid observed in E600-treated cells
is difficult to interpret.

Histochemically an increase in phospholipid

staini.ng was visible in a perinuclear location, but ultrastruct:urally
this area appeared essentially normal.

If the increase were due to

inhibition of a lysosomal phospholipase, the
to be stored in the lysosome
staining.

~d

~ipid

would be expected

to be discernible by histochemical

If the storage were cytoplasmic or represented an increase

in the amount of membz'ane, it would be difficult to detect histochemically.

The major increase in membranes in E600-treated cells appeared to
be due to a vast increase in the number of lysosomes.
least account for a part of the phospholipid increase.

This may at

An increased

number of lamellar bodies may also have accounted for some phospholipid
storage.

Because phospholipid degradation requires cleavage of glyceryl

fatty acid esters and phosphate esters, it is quite possible that E600induced inhibition of a phospholipolytic enzyme is also involved.
The evidence appears, good. tha t, as in Wolman t s disease,

the storage of triglycerides and cholesteryl'esters in E600-treated
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cells occurs in lysosomes.
lysosomal enzyme.

Firstly, E60D inhibited acid lipase, a

Acid lipase deficiency results in lysosomal lipid

storage in Wolman's disease (16,101).

Secondly, the cholestery1

esters in both Wolman's disease and E600-treated cells had the same
fatty acid pattern as
they had not been

~holesteryl

~egraded.

esters in FeS, suggesting that

Since cholesteryl esters are normally

taken up at receptor sites and transported to the 1ysosomes for
degradation by acid lipase (9), the lack of degradation suggests
that the deficiency of acid lipase resulted in the storage of the
cholesteryl esters in the lysosomes.

A third line of evidence that

the stor.age of lipid in E600-treated cells is lysosomal is indicated
by the morphology of the oil red 0 granules.

In Wolman's disease

....,
and E60D-treated cells, the granules were small and close to the

nucleus.

In contrast, cells treated with large amounts of free

fatty acid or cholesterol stored the lipid in large droplets at
the periphery of the cells. Because little lipid was seen in areas

where the lysosomes were most abundant, lipid transported to these
areas may have been degraded.

A fourt·h line of evidence that the

storage was lysosomal is the presence in E600-treated cells of a
clear perinuclear zone surrounded by

numerou~

granules that stained

with oil red 0 and neutral red, appeared as bumps by SEM, and as

dense bodies containing lipid clefts by !EM.

The similar appearance

of the clear zone suggests that these structures are identical

and, because they stained with both oil red 0 and neutral red, that

they represent lipid-containing lysosomes.

As a fifth line of

evidence, the electron-dense structures that sometimes contained lipid
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clefts by TEM could be shown to be associated with

colloida~

gold

particles, indicating that they were probably secondary lysosomes.
In several animal model systems of atherosclerosis, cholesteryl
esters have been shown to be stored in 1ysosomes of cells of the
~

aortic wall (22,114,115).

An accompanying increase was observed

in lysosomal size (22,115), number (22,115) and activity (114).
Increased lysosomal number and activity have also been reported
in aortic smooth

ml~cle

cells of hypertensive rats (116).

Aortic

smooth muscle cells have acid lipase activity (15,23) and evidence
indicates that this activity may be reduced in atherosclerosis (26,117,118)

and hypertension (25).

It has been proposed that a relative deficiency

of acid cholesterol esterase (22-24) or acid esterase

which appear

to be identical to acid lipase (13,15), may playa

role in the pathogenesis of atherosclerotic disease.
from patients

Arterial accumulation of fat is a typical finding

in Wolman's disease (8).

Advanced atherosclerosis has been seen in

bwo of the three autopsies performed on patients
sto~age

Autopsy findings

with acid lipase deficiency diseases, give support

to this hypothesis.

ester

(25,26'~f7,ll8),

with cholesteryl

disease (5,7).

Although aortic smooth muscle cells and fibroblasts in culture
store little lipid, when treated with certain chemicals they can
be induced to store cholesteryl esters and reproduce features of
atherosclerotic cells.

Cells treated with low density lipoprotein

(LDL) modified to carry a strong positive cha,rge by a covalent linkage
to N,N-dimethyl-l,3-propanediamine (DMPA) stored massive amounts

of cholesteryl esters (119-121).

The lipid droplets did not appear
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to be membrane limited in either fibroblasts. (120) or smooth muscle
cells (121).

DMPA-IDL appears to be a useful method of inducing

non-lysosomal cholesteryl ester

sto~age.

Fibroblasts treated with

25-hydroxycholesterol also appeared.to store cholesteryl esters
in the cytoplasm

(9,80,~22).

Cytoplasmic esterification is normally

stimulated by an increase in cytoplasmic cholesterol which suppresses
the cholesterol synthetic pathway (9,80,122).

This may result from

the hydrolysis of cholesteryl esters in the lysosomes.
hydrolysis of

en~ogenously

Cytoplasmic

synthesized cholesteryl esters is not

dependent on lysosomal acid lipase and occurs equally well in normal,
choles'teryl ester

sto~age

disease, and chloroquine-treated cells

(9) •

Chloroquine treatment appears to induc'e lysosomal cholesteryl
ester stor.age in fibroblast (9,80,120,123) and aortic smooth muscle
(124) cultures, and its use has been proposed in a model system
for studying the role of the lysosomal system in atherosclerosis
(124).

Chloroquine-induced cholesteryl ester storage probably results

from the inhibition of acid lipase (20,80) in
role for acid lipase in the

etio~ogy

keep~ng

.

-

with the hypothesized

of atherosclerosis.

However,

chloroquine inhibits other lysosomal hydrolases involved in the
degradation of mucopolysaccharides (125) and proteins (126).

These

results are tho.ught to stem from increases in the lysosomal pH (127).
Chloroquine may have other complex actions on cells, i.ncluding inhibition
of receptor-mediated endocytosis of lysosomal enzymes (45).

Because

E60o-induced accumulation of cholesteryl esters appears to be caused

by specific inhibition of acid lipase whereas chloroquine-induced
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accumulation is.thought to result·from a.non-specific alteration
of the intralysosomal environment, E600 may be more suitable for
inducing lysosomal cholesteryl

estersto~age

as a means of studying

atherosclerosis in vitro.
Chloroquine-indJced cholesteryl ester accumulation has been
reporte~

to be maximal after 48 hr (124) and the cholesteryl ester

accum~llation

has not exceeded 102.0 .J.1glmg protein (123).

E600-induced

lipid accumulation thus results in greater ch.olesteryl ester accumulations
th&~

chloroquine (Table 8) and the lipid continues to accumulate

with time

(~igs. 20~22),

a situation that may be more analogous

to the development of atherosclerosis.

In addition, E600-trea ted

cells exhibit increased numbers of lysosomes (Figs. 32,44) as
been observed in atherosclerosis (22,115).·

in chloroquine-treated cells.

~s

This has not been shown

The stored lipid, in chloroquine-

treated cells, is still bound to the protein component of LDL (9,80).

In Wolman's disease, the protein appears to be

(10).

degrad~

normally

Whether or not the chloresteryl ester stored in atherosclerosis

or in E600-treated cells is ·still bound to protein is DOt presently
known.

There is much room for further research on Wolman's disease
and E600-treated cells and on their relation to atherosclerosis.

The major difference-between the lipids stored in Wolman's disease

and E600-treated cells was the large increase in phospholipid storage
after E600-treatment.

Altho,ugh a preliminary separation of the

phospholipid classes was carried out, further phospholipid analysis
might prove

reward~ng.

Cells could be, grown in the presence of
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E600 and ino,rganic phosphate with radiolabeled .phosphorus.
extracting.the lipids and

separat~ng

After·

the phospholipids by two dimensional

thin layer chromatography, the phospholipid spots could be scraped
from the plates, extracted from the

silic~

gel, and the radioactivity

measured on a liquid sc~tillationcounter.

This experiment would

give a more accurate numerical representation of the phospholipid
classes stored in E600-treated cells.
Chloroquine has been shown to inhibit lDL degradation for
seven hr after its removal (80).

It would be

interest~ng

how long after removal of E600 the treated cells
the stored
after

cholestel~l

grow~ng

esters.

~egin

to determine

to hydrolyze

Replicate culture dishes of cells,

for 24 hr in lipoprotein deficient serum with or

w~thout

E600 J could be sv.Titched to a' medium containing cholesteryl ester-

LDL in which the cholesterol has been radiolabeled.

At this time

and every hr afterward, lipid could be extracted from duplicate
dishes and separated by thin layer chromatography.

The spots could

be scraped, the lipid extracted, and the extent of radioactivity
measured on a liquid scintillation counter.

The total amount of

free radiolabeled cholesterol would represent the cholesteryl esterolytic
activity (9).

The results of this experiment should show clearly

at what time activity returns to E600-treated cells as well as

demonstrating ,again that the E600 initially causes inhibition.
Goldstein et ale (9) demonstrated that when substrate built
,up sufficiently in cholesteryl ester

sto~age

disease cells, the

monolayers showed 1/3 the activity of normal cells altho,ugh extracts

118
from the cells .showed only 5% of . the normal activity.

It i.s possible

that the small difference present in acid lipase activity of Wolman's
disease and cholesteryl ester

sto~age

disease cells may be

~agnified

when increased substrate is presented to the enzyme in intact cells,
result~ng

diseases.

in the extre,e difference in symptoms between the two

This could be tested by

grow~ng

replicate

culture dishes

of cells (normal, cholesteryl ester .stor.age disease, and Wolman's
disease) for 48 hr in lipoprotein deficient serum and then switching
them to

~

growth medium containing cholesteryl ester-LDL in which
At this time and every hr

the cholesterol has been radiolabeled.

aftervlard, duplicate culture dishes would be extracted and prepared
as outlined in the experiment above.
dist~nguish

Not only might this experiment

""
betwe.en cholesteryl ester stor_age disease and Wolman's

disease cells, but, if the Wolman's disease cells do show some residual
acid lipase &ctivity, it

~ight

explain why E600-treated Wolman's

disease cells, in which residual acid lipase
stored additional

t~iglycerides

activi~

could be inhibited,

and cholesteryl esters.

The effect

of E600 could be tested in this system to determine if the residual
acid lipase activity is truly inhibited.
Cytoplasmic cholesteryl ester synthesis and hydrolysis have
been shown ,to be normal in cholesteryl ester storage disease and

chloroquine-treated cells (9).

Because E600 inhibits esterase

enzymes whereas chloroquine inhibits lysosomal degradat.ion, E600

may well have an effect upon the cytoplasmic cholesteryl ester
hydrolase and perhaps even the synthetase (fatty acyl-CoA:cholesteryl
acyltransferase).

The cytoplasmic cholesteryl ester hydrolase
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may not be as resistant to E600 as acid lipase, so different E600
concentrations should be evaluated.

to compare cholesteryl ester

sto~age

.It would also be

interest~ng

disease and Wolman's disease

cells, to determine if a difference in this system may account
for the more serious na\ure of the latter disease.

Normal, cholesteryl

ester s tor,age disease and Wolman's disease cells, after incubation

in lipoprotein deficient serum, .would be incubated in replicate culture
dishes ltlith LDL and radiolabeled oleate with or without E600 for

20 hr.

This would label endogenously synthesized cholesteryl esters.

The cells would be switched to lipoprotein deficient serum with or
without E600.

At this time and at intervals up to 24 hr, the

cholesteryl oleate would be extracted from replicate dishes, separated
..,;"\

by thin layer chromat,ography, and the amount of radioactivj.ty in

the cholesteryl ester spots would be measured on a liquid scintillation
counter.

The decrease in cholesteryl ester radioactivity serves

as a measure of cytoplasmic cholesteryl esterase activity and the

initial level measures synthetase activity_
Because an increase in lysosome number was seen in E600-treated
cells, it would be interesting to see if other

event~

that have been

reported in animal model systems of atherosclerosis also occur in
E60o-treated cells.

The activity of other lysosomal hydrolases in

E600-treated cells should be tested to determine if similar increases
to those seen in atherosclerotic cells (114) occur.

In addition,

studies of lysosomal phospholipases would be worthwhile.

No increase

in lysosomal size was noted by !EM in E600-treated cells, though
authors have reported this in atherosclerosis model systems (22,115).·
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Reduced lysosomal density due to lipid accumulation was reported

in aortic cells in rabbit experimental atheroma (114).
the massive lipid

sto~age,

Because of

and the apparent involvement of lysosomes

in E600-treated cells, a similar result

~ght

be expected.

This

could be tested by dilferential cent~i~ugation to purify lysosomes
and centrif,ugation in

sucros~

gradients to determine the density

of the lysosomes.
In order to determine the importance of acid lipase in the

etiology of atherosclerosis and how closely E600-treated cells resembled
atherosclerotic cells it would be important to determine if the
cholesteryl ester remains bound to the protein component of LDL
as in chloroquine-treated cells (9,80) or if the

pro~ein

is degraded
...
~

normally as in cholesteryl ester storage disease (91'10) and Wolman's
disease (10).

If both protein and cho1esteryl ester degradation were

inhibited, a general overloading of lysosomes with relative decreases'
in proteolytic and cholesteryl e.sterolytic hydrolase a,ctivities would

be indicated, whereas if only cholesteryl ester

degra~ion

a relative deficiency of acid lipase would be indicated.

were inhibited,
In an animal

rendered atherosclerotic by cholesterol feeding, th,eaorta could be
125
.
removed and perfused with
I-labeled LDL or cholesteryl ester-LDL
with radiclabeled cholesterol.

The ability of the tissue to degrade

the LDL and cholesteryl esters could be compared to that of normal

animals.

For E600-treated cells in culture, after incubation of replicate

culture dishes in lipoprotein deficient serum, the labeled LDL and
E600 could be added.

At this time and every hr after this, duplicate
125
.
l~labeled
cultures would be extracted with trichloroacetic acid for
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acid soluble material (9,10,80) 'or with chloroform-methanol for
radiolabeled free cholesterol (9,10) and the radioactivity measured
on a liquid scintillation counter.
The results reported
load~ng

cultured cells

here.s~ggest

~ith

that E600 may be useful for

cholesteryl esters in order to study the

cleari:ng of cholesteryl esters accomplished by dlfferent
,agents.

Stein

~

ale (123,124)

density apolipoprotein and

pharmaco~ogica1

showed that medium enriched in

sph~ngomyelin.led

~igh

to increased depletion

of cellular cholesterol and cholesteryl ester in cells pretreated
with chloroquine.
experiments.

A

E600 pretreatment could prove useful in similar

d~ug

could also be tested for its ability to block

IDL uptake by treati,ng cells in the presence of E600.

were effective, there would be a
accumulation.

If the dt::ug

reduction in E600-induced lipid

E600 trea.tment could potentially be employed on any

cell type which can be maintained in vitro.
In addition, E60D might prove useful in assessing the role
of acid lipase in the lysosomal

~igestion

and

p~gocytic

micro~rganisms,

alth~ugh

in

of more comp1ex substances
cells E600 would probably

inhibi.t other esterase enzymes as well as acid lipase.
~

great deal of study remains to be done on acid lipase.

enzyme has not been purified nor has the: gene been mapped.

in this area may have important therapeutic consequences.

The

Studies
Enzyme

replacement therapy appears to be helpful in Fabry's disease and Gaucher's
disease (128), two lipid storage diseases in which symptoms are not
due to lipid accumulations in the central nervous system.

To obtain

sufficient acid lipase for enzyme replacement therapy would probably
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requir~

Once
~ght

genetic engineering utilizin.g.recombinaut DNA techniques.

l~rge anlounts

of purified acid lipase can be obtained, not only

enzyme replacement therapy be of use in treating patients with

Wolman's disease and cholesteryl ester storage disease, but more importantly
it might also permit

th~

reduction of.atherosclerotic plaques, providing

a safe and simple therapy for what is today the leading cause of death

in the United States.
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